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Abstract 
 
The aim of this thesis is to develop a method to produce melt-derived bioactive glass 
scaffolds, without the glass crystallizing into a glass-ceramic, while establishing an 
interconnected pore network suitable for bone tissue regeneration. In order to 
achieve this, the scaffold must have the ability to closely mimic the porous structure 
of cancellous bone and its mechanical properties. Two bioactive glasses were used in 
this project, both are modified from the Bioglass
® 
composition: ICIE 16 (49.46% 
SiO2, 36.27% CaO, 6.6% Na2O, 6.6% K2O and 1.07% P2O5, all in mol%) and ICIE 
16M (49.46% SiO2, 27.27% CaO, 6.6% Na2O, 6.6% K2O, 3% ZnO, 3% MgO, 3% 
SrO and 1.07% P2O5, all in mol%). Gel-cast foaming produced improved pore 
networks over alternative methods for producing porous scaffolds. There are many 
variables in the process. An initial protocol was established and each of the variables 
assessed systematically. The relationships between each component, the gelling time 
and the foam body volume were evaluated to develop an optimized protocol for the 
process. The size of the glass powder was critical in determining the sintering 
efficiency. A suitable drying and sintering program was also determined to prevent 
crystallization of the glass and formation of crystal species from by-products of the 
process. The scaffolds were characterized in terms of the interconnect size, the rate 
of hydroxycarbonate apatite (HCA) formation in simulated body fluid (SBF) 
solutions, the ion release rate and the compressive strength. The results showed that 
ICIE 16M sintered better and was stronger than ICIE 16, however in the bioactivity 
aspect of view, the rate of HCA formation in SBF was faster for ICIE 16 than ICIE 
16M.  
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1. Introduction 
The number of people suffering from pathological bone diseases and 
non-healing bone fractures are increasing every year. Approximately 500,000 
bone grafting procedures are performed each year in United States and over 2.2 
million worldwide [1]. Autografts (bone transplanted from a donor site of the 
patient, e.g. the iliac crest) remain the gold-standard treatment for bone defects 
and non-healing fractures, however they are very limited in supply and recovery 
time can be long and painful. Allografts (irradiated cadaveric bone from bone 
banks) in comparison are more available and at a lower cost, however their 
mechanical properties can be poor and there is risk of disease transmission [2]. 
Alternatively implantation is a popular choice, which is the use of prosthetic 
materials to replace the damaged tissue. In orthopaedics, implants that replace 
bone are usually metallic; they have a limited lifespan because of problems such 
as stress shielding (the decrease in bone density due to lack of stress applied to 
the surrounding bone tissue of the implant as a result of bone remodeling itself 
according to stress applied, i.e. Wolff’s Law) and inflammation (the reaction of 
the immune system to foreign substances inside the body), which lead to 
re-implantation and more pain for the patients. Meanwhile, diseases such as 
osteoporosis (the decrease in bone mineral density and the disappearance of 
bone tissue due to low hormone level, as a result bone grows more weakly and 
bone fracture risks significantly increases) are still uncureable, although 
treatments are available to both prevent and slow down the progress of the 
disease, for example modifying life style or take certain types of medicine 
accordingly. The increasing number of patients who suffer from bone injury, the 
high cost of operation, plus the lack of bone stock in autografts, while 
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allografting and implantation both had strong side effects; as a result, scientists 
have focused towards bone-tissue engineering. No one has yet succeeded in 
regenerating the bone tissue and tissue engineering of bone is a strategy that has 
not seen clinical translation. Conventional strategies are to build a 
three-dimensional bone structure mimicking scaffolds for in vitro tissue 
regeneration, where the cells were seeded onto the scaffold and grown into 
desired tissue, which was then placed in the targeted site. Scaffolds that can 
regenerate tissue in-situ while resorbing at the same rate as the new tissue 
formation and releasing non-cytotoxic and beneficial dissolution products is the 
ultimate goal for tissue regeneration, which is also the aim of this project 
  
There are many types of materials available to fabricate such scaffolds, 
including ceramic-polymer composites, bioactive glasses (BGs), hydro-gels, 
hydroxyapatite coated metals, hybrids and many more. Since the invention of 
Bioglass
®
 (46.1% SiO2, 26.9% CaO, 24.4% Na2O and 2.6% P2O5, all in mol%) 
[3], which is the first bioactive material as it would interact with the host tissue, 
BGs have been thoroughly studied for their excellent ability to establish a close 
bond to the bone without the formation of fibrous capsulation. In addition, BGs 
can stimulate osteogenesis, i.e. promote bone growth [4-5].  
 
Glass is an amorphous material, supercooled from its molten state to prevent 
crystallization occurring, which means it has a random network very similar to 
that of a liquid. It is homogenous and very stable at room temperature. However 
given the required amount of energy, the glass can crystallize again and become 
a ceramic or glass-ceramic.  
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BGs can be produced by two methods: traditional melt-casting and sol-gel 
processing. Whilst sol-gel derived BGs can be easily made into 3D porous 
foams with very high porosity, interconnectivity and surface area; conventional 
BGs cannot. For example, Bioglass
®
 has a very small processing window, 
which means its glass transition temperature Tg (glasses are supercooled from 
their molten state before nucleation could take place and the molecular 
arrangements are disordered with adequate cohesion between the molecules to 
maintain a solid state. Tg is the energy barrier significantly below the melting 
temperature Tm that the glass has to overcome in order to become less rigid and 
less viscous so it can flow slightly) and crystallization temperature Tc (where 
the amorphous molecular structure becomes well ordered and 
thermodynamically stable) are very close together [6-7]. The narrow sintering 
window causes the glass to crystallize shortly after heated beyond Tg. Once the 
crystallization takes place, the bioactivity of Bioglass
®
 drops extensively [6, 8-9] 
while the degradation behavior becomes unpredictable [10].  
 
However a scaffold can only be made from powder by going through sintering, 
sufficient amount of fluid flow is the key to compose the structure. As a result, 
Bioglass
®
 can only be used in monolith or powder form and contribute in 
coating of other scaffolds or implants. Perioglas
®
, Novabone
®
 by NovaBone 
Products LLC. US; NovaMin
®
 by Sultan Healthcare, US and Vitoss
™
 and 
Vitoss
™
BA by Orthovita Inc. US are the only commercial products [11-13]. 
Later researches have shown that this crystallization in Bioglass
®
 would retard 
the formation of hydroxycarbonate apatite (HCA) layer [14-19] and would 
therefore significantly reduce the bioactivity.  
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In order to solve this problem, the composition needs to be modified to provide 
a better sintering window (the gap between Tg and Tc) so the glass particles will 
have time to sinter together without crystallizing. The wider the sintering 
window, the better the sinterability of the glass. It is well studied that the 
bioactivity can be controlled by varying the composition of the BG [20-22], new 
sinterable melt-derived BGs were produced whilst maintaining the bioactivity of 
the Bioglass
®
. The variation in the composition has led to the difference in the 
glass properties and hence affected the performance of the scaffold in terms of 
the viscosity during sintering, the processing window, the foam structure (which 
determines the pore size and interconnect size), the dissolution rate and the 
HCA deposition rate. 
 
This thesis is mainly focused on achieving a porous 3D interconnected structure 
from a melt-derived bioactive glass. A background to the bone tissue 
engineering and the history of biomaterials is discussed in Section 2.1 and 2.2; 
followed by a detailed assessment of bioactive glasses in Section 2.3. Section 
2.4 reviews the requirement of an ideal bone scaffold and the range of scaffold 
materials. The review will end in Section 2.5 with the history and development 
of different types of techniques that were used to produce porous ceramic foams, 
in particular the gel-casting technique. The development and characterization of 
gel-cast melt-derived bioactive glass scaffolds is illustrated in Chapters 3 – 6; 
the experimental techniques and parameters involved will be described in 
Section 2 of each chapter, followed by a comprehensive discussion of the results 
in Section 3. Conclusions are drawn in Chapter 7 with a suggestion for future 
work. 
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2. Literature review 
2.1 Human Bone 
Bone is a vital part of the human body, it supports the body weight, enables us 
to move, and protects the other organs from external damage. Bone also stores 
important minerals such as calcium and sodium inside the body, and produces 
red and white blood cells. The bone structure illustrated in Figure 2.1 is 
incredibly complicated, but essentially bone is a nano-composite that consists of 
collagen fibre with carbonated hydroxyapatite crystals. This combination allows 
the bone to be both strong in compression, tough and lightweight, while 
fulfilling its other functions [2, 23-24]. The density and composition of bone 
varies with gender, age and whether it was pathologically affected [25]. 
  
 
Figure 2.1  Schematic diagram of bone structure [26] 
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There are two types of bone, trabecular and compact, as shown in Figure 2.2. 
The outer layer is called the compact bone, which contributes 80% of the weight 
of a human skeleton and is therefore very dense and hard. It is formed by 
multiple stacked layers of osteon, which is the fundamental bone unit. It 
consists of coiled up collagen fibers with HCA crystals in-between the ends and 
is hollow centered to allow the blood vessels to go through. The second part of 
osseous tissue is known as the trabecular bone, which fills the inner cavity of 
long bones. It has lower density and strength compared to the compact bone, but 
is very high in surface area [27]. The external layer of trabecular bone contains 
red bone marrow and most of the arteries and veins of bone organs are also 
found in here. It is this area where the bone scaffolds aim to repair. The 
mechanical properties are summarized in Table 2.1. 
  
 
Figure 2.2  Graphic illustration of the two different types of bone [28] 
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Table 2.1  The mechanical properties of compact and trabecular bone [26] 
Property Compact Bone Trabecular Bone 
Compressive strength (MPa) 100-230 2-12 
Flexural, tensile strength (MPa) 50-150 10-20 
Strain to failure (%) 1-3 5-7 
Young’s (tensile) modulus (GPa) 7-30 0.5-0.05 
Fracture toughness (KIC) 2-12 n/a 
 
Bone has the ability to heal itself but only to a certain extent, for damage caused 
by pathological diseases or pathological fractures, bone cease to repair itself; 
biomaterials are hence developed in order to help restore the continuity in the 
bone structure. 
 
2.2 Bone tissue engineering 
Tissue engineering aims to develop biological substitutes to maintain, restore or 
improve a certain type of tissue or organ. For bone tissue engineering, there are 
2 major techniques: in vitro and in-situ (in vivo) tissue regeneration. By the 
means of their names, the in vitro method is to harvest cells and culture them 
onto a scaffold where the target tissue is grown to matured state before 
implantation, while the in vivo method consists of implanting only the scaffold 
to the defected site, as the cells grow and attach themselves to the structure, the 
scaffold will resorb at the same rate as the new bone grows. [29] 
 
There are limitations to both methods; the in vitro method is preferred in the 
cases of older patients as their bone tissue regeneration rate is slower than the 
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younger patients or at the presence of large areas of defects [30], whereas the in 
vivo method requires the scaffold to be mechanical identical to the host bone. 
Both scaffolds should resemble the bone structure as closely as possible in order 
to fulfill their duties. In general, the ultimate goal is to create a scaffold that 
regenerates bone tissue in vivo as the in vitro method requires significant 
amount of waiting time before the implantation.  
 
There is a wide selection of candidates for the scaffolding material and a 
number of requirements must be met for an ideal scaffold, which will be 
discussed in the following sections. 
 
2.3 Biomaterials for bone tissue engineering 
The use of synthetic materials as a way to replace damaged tissues has been 
studied and practiced for a long time. All materials that are implanted into the 
body elicit a response from their host tissue [31]. There are 4 types of possible 
responses as shown in the table:  
 
Table 2.2   Consequences of Implant-Tissue Interactions [31]  
Implant-Tissue Reaction Consequences 
Toxic Tissue dies 
Biologically nearly inert 
Tissue forms a non-adherent fibrous 
capsule around the implant 
Bioactive 
Tissue forms an interfacial bond with 
the implant 
Dissolution of the implant Tissue replaces the implant 
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For the first implants, the goal was to find an ideal biomaterial that would evoke 
minimum body responses to the implantation of the material. The most 
important criteria were precise fixation of the implant and adhesion in the 
biomaterial-tissue system [29, 32]. This had led to the research of first 
generation of biomaterials, which included the use of stainless-steel, 
cobalt-chrome alloys, titanium alloys and polymers with very large molecular 
weights. They were termed bio-inert materials. However all bio-inert implants 
were found to be encapsulated by a non-adherent fibrous tissue as a result of 
protective mechanism mainly by macrophages and/or foreign-body giant cells 
of the host tissue [33]. The thickness of the fibrous capsule might vary but it 
would generally isolate the implant from the tissue so that the implant-bone 
interface was poor, leading to micro-motion of the implant and loss of bone. All 
metal orthopaedic implants have a limited lifespan due to wear particles and a 
modulus mismatch between the implant and the bone (stress shielding) causing 
bone loss, which eventually leads to loosening of the implant. As life 
expectancy is continually increasing, the survival time of bioinert implants is 
not enough for many applications. The focus has since shifted from the 
replacement of tissues to the regeneration of tissues, in order to satisfy the 
growing need for very long term orthopaedic repair [34].  
 
Second generation of biomaterials were developed, which were bioactive and 
biocompatible, i.e. they could establish a chemical bond to the host tissue and 
would not evoke any harmful responses from the body when implanted. A great 
example is the synthetic hydroxyapatite (HA), which is the closest synthetic 
form to the mineral part of bone tissue and because of this feature it is the most 
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widely applied bioactive implant material. While HA does not elicit 
immunological reactions, its dissolution rate and ion exchange rate is very low 
and hence its ability to form a hydroxycarbonated apatite (HCA) layer is weak 
[30]. The formation of the HCA layer marks whether the material is able to 
bond to the bone. A similar material to HA is tricalcium phosphates (TCPs), 
which are again very popular as a bioactive implant material, however they have 
similar problems to that of HA and they are very unpredictable in terms of 
degradation rate [35]. 
 
Third generation of biomaterials are those ones that encourage cell attachment, 
differentiation and growth whilst the implant itself would gradually dissolve 
away at the same rate as the tissue grows, leaving the defect site replaced by the 
natural tissue [36], for example the BGs. The development of porous scaffolds 
from bioactive and resorable materials with sufficient mechanical properties 
would be a large step towards successful bone regeneration. 
 
2.4 Bioactive glasses 
There is a large difference in the bonding rate of the vast variety of bioactive 
material to the host tissue, i.e. the bioactivity, so that they are further classified 
into two categories. Bioactive glasses have been shown to bond to bone and soft 
tissue as well as to stimulate osteoblast differentiation and cell growth, i.e. they 
are osteoproductive, a good example is the Bioglass
®
 [4-5]; Synthetic HA [37] 
and TCP are only osteoconductive, which means that they encourage cell 
attachment and growth along their surfaces from the bone-implant surface 
[38-39].  
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As aforementioned, the glass has to have <59 mol% of SiO2 in its composition 
in order to be bioactive [40]; within that limit, there are only a few composition 
that are highly bioactive, which lies within the centre region of the schematic 
diagram shown in Figure 2.3. Region B at the top of the diagram represents the 
compositions of the glass that will act as an inert material due to high network 
connectivity values and form fibrous capsule at the implant site, whereas region 
C represented the ones that degrade in 10-30 days and the compositions in 
region D will not form glasses [41].  
 
Phosphorus (P) plays an interesting role in BGs, it is not necessary to include it 
in the composition in purpose of HCA formation but the inclusion of 
phosphorus in a small amount will increase HCA crystallization rate, due to 
phosphorus accelerate glass degradation when released, resulting a higher 
degree of supersaturation in the body fluid, and faster crystallization rate of the 
HCA layer [42]. In addition, presence of P balances pH level around the implant 
site, if the pH is too high bone bonding mechanism will not occur at the 
tissue-implant interface [43]. P-free BGs forms a non-uniform HCA layer along 
its surface that penetrates through the silica layer, result in a weaker 
bone-bonding strength compared to the P-containing BGs [40, 44].  
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Figure 2.3  Diagram in wt% illustrating the compositional dependence 
of bioactivity for glasses related to 45S5 [45] 
 
Even the slightest alteration in the glass composition could evoke a radical 
change in the dissolution rate and mechanism [46-47]. In order to expand the 
sintering window, various ingredients are added into the original composition. 
Brink et al. found that bioactive glasses in the system 
Na2O-K2O-MgO-CaO-B2O3-P2O5-SiO2 have a large working range [48], and 
borosilica bioactive glasses was proved to be bioactive as well as biodegradable 
with a controllable degradation rate by varying the boron content in the glass 
composition. Borate as the major degradation product is known to be cytotoxic 
in a static culture environment [49], although the environment is dynamic in 
vivo and the toxicity is more likely to be alleviated, it is still a major concern. A 
desire to develop safe and processable melt-derived bioactive glass is 
unavoidable. Hill et al. and his research group carried out extensive studies on 
the role of different oxides contributed, termed as the Mixed Alkali Effect 
(MAE) [50] and invented the ICIE 16 & ICIE 16M glasses, which are chosen to 
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be applied in this project [37, 51] to the sinterability (Table 2.3) and bioactivity 
of the modified Bioglass
®
 compositions. 
 
Alkali oxides consist of Group 1 elements except for hydrogen (Li, Na, K, Rb, 
Cs and Fr) and the MAE refers to the non-linear change of ionic related 
properties of a glass (e.g. electric conductivity, viscosity and ionic diffusion) by 
the substitution of one alkali oxide for another. The non-linear relationship is 
due to decreased mobility of the individual ions, which is caused by the 
presence of a second ion. Changes in other properties such as molar volume, 
density and thermal expansion coefficient remain linear. The MAE is commonly 
observed in silicate, phosphate, borate, halide and germinate glasses. [50, 52-53] 
Incorporating Na
+
 and K
+
 into BG composition would reduce ion diffusion rate 
but increase chemical durability than single alkali, as well as allow glass 
formation at lower temperatures glasses, all because of the ion migration rates 
were restricted in mixed alkali glasses [37]. This enables the glass properties to 
be tailored to suit specific applications, e.g. controlled degradation rate without 
compromising too much bioactivity. 
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Table 2.3   The role of different ions in melt-derive silicate BG and their 
effects on the sinterability of the glass 
Ions Role Effect on sinterability 
Si4+ Network Former 
Forms the SiO2 network which is the essential 
structure of glass 
P5
+ Network Former 
Forms a P2O5 network (phase separation in 
SiO2) 
Na+ Network Modifier 
Reduces viscosity and Tg due to disruption of 
the glass network, reduces Tc but not 
siginificantly 
Mg2+ 
Network 
Intermediate 
Effectively increases sintering window width 
[54] but also reduces viscosity and solubility 
with increasing content [55] 
Zn2+ 
Network 
Intermediate 
Increases sintering window width 
Sr2+ Network Modifier 
Decreases both Tg and Tc without changing 
the window width 
K+ Network Modifier 
Reduces viscosity and Tg due to disruption of 
the glass network 
Ca2+ Network Modifier 
Reduces viscosity, Tg and make glass less 
soluble in water 
 
 
SiO2 forms the bulk of the glass network and is therefore a network former, it is 
also a major contributor to the bone mineralization and gene activation activities 
[34]. According to Zacharisen’s random network theory, there are 3 types of 
oxides participating in the glass formation system [56] (Figure 2.4). Network 
formers such as Si, P and B, form bridging oxygen (BO) bonds, which are the 
type of bond that is shared between an oxygen atom and any two network 
former molecules, i.e. the O in Si-O-Si, P-O-Si, P-O-P or B-O-B is a BO. They 
generally have a coordination number of 3 or 4. A network modifier forms 
non-bridging oxygen (NBO) bond, which is the bond between any other oxygen 
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that is not shared by the two tetrahedral but the surrounding ions, this results in 
a weakened glass network, they have a coordination number of 6 or less. A 
network intermediate with coordination number of 6 or 8 can function either as 
a network former (but on their own they cannot form a glass network) or as a 
modifier depending upon the glass compositions involved [57]. In general, the 
role of the cations depends on the size of the ion, the coordination number and 
the strength of the bond it forms with oxygen. 
 
 
Figure 2.4 Schematic diagram of the soda-lime phosphosilicate glass 
structure showing BOs and NBOs as well as network formers, 
intermediates and modifiers 
 
The number of NBOs in a glass is important because it determines the network 
connectivity (NC) and the crosslink density of the glass, which are the average 
number of bonds that link each repeat unit in the network and the average 
number of additional crosslinking bonds (above two) for elements other than 
oxygen which form the network backbone, respectively. The more the NBOs, 
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the less BOs, the smaller the network connectivity and the more loosely packed 
the glass structure, which gives faster dissolution rate and the glass is hence 
more bioactive. NC is closely associated with the bioactivity of the glass, the 
lower the crosslink density, the lower the Tg and the more ‘broken’ the glass 
network, i.e. the faster the reactivity and solubility of the glass [37]. A crosslink 
density of 0 is equivalent to a network connectivity of 2, therefore the closer to 
2 is the network connectivity, the better the glass is in terms of sinterability and 
bioactivity [58]. The value of NC can be calculated using Equation 2.1: 
 
                            
                           
                               
 
 
For a pure silicate glass, the network connectivity is 4 as each silica is 
covalently bonded to 4 oxygens, i.e. 4 BOs; but for a 50% SiO2 – 50% Na2O 
glass the NC is 2, as there are now only 2 BOs as the other 2 are each bonded to 
2 Na
+
 ions via ionic bonding. 
 
The incorporation of the ions, which when released is not only non-cytotoxic 
but beneficial to the body, another reason for incorporating them into the 
composition. Network modifiers such as Na
+
, K
+
 and Ca
2+
 ions lower the NC by 
disrupting Si network and promoting formation of non-bridging oxygen bonds 
[48]. Osteoporosis is caused by the inactivity of osteoblasts (cells that form and 
build bone tissue) and the activity of osteoclasts (cells that remove and resorb 
bone tissue), Sr
2+
 promotes osteoblast activities and inhibits osteoclast activities, 
while acting as a network modifier [59]. Mg
2+
 ions control the dissolution rate 
[60] and if the content is >7 mol% they slow down the rate of HCA layer 
(2.1) 
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formation, they also increase the thickness of HCA layer [61], whereas Zn
2+
 
ions control the reaction between the glass-ceramic and SBF and enhance bone 
regeneration [62]. The bioactivity is not only influenced by the calcium content 
and the NC values, it is also directly related to phosphorus content in the glass 
[63] as it contributes to the formation of HCA layer. An increase in P2O5 content 
increases the NC but increases the bioactivity at the same time, this intriguing 
phenomena was discovered by O’Donnell et al. [64]. The enhanced apatite 
formation is due to the presence of orthophosphate in the silica network, which 
leads to continuous phosphate leaching at the contact with the SBF and the 
surface area increases rapidly. Increase in P2O5 also increases the Tc of the glass 
[63-64] whilst weakens the compressive strength of the glass [63, 65]. 
 
Of all the present bioactive materials, only handfuls are highly bioactive 
materials including certain compositions of BGs, which have similar 
compositions to Bioglass
®
. They bond to bone much quicker than bioceramic 
materials as they are amorphous. The bone bonding mechanism [45], also 
known as the Hench mechanism, is a 11-stage reaction, based on 
soda-lime-silica glass corrosion. Dissolution starts with rapid ion exchange of 
the network modifiers such as Na
+
 or K
+
 with the ions in the surrounding 
solution, such as H
+
 or H3O
+
. The breakdown of the silica network, the breaking 
of Si-O-Si bonds when the local pH increases above 9, results in the detachment 
of soluble silica from the bulk glass in the form of Si(OH)4, leaves the surface 
rich with silanol (Si-OH) groups, which eventually forms an alkaline depleted 
layer rich in SiO2. The Ca
2+
 ions will then migrate from inside of the glass into 
the solution, and as it passes through the silica-rich layer it is met by PO4
3-
 ions 
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in the solution, which results in the formation of a CaO-P2O5-rich film on top of 
the silica-rich layer, followed by the growth of the film as the calcium, 
phosphates, hydroxyls and carbonates from the solution are incorporated into 
the system. The crystallized form of this film is the HCA layer. The 
differentiation of stem cells is activated by the adsorption and desorption of 
biological growth factors taking place in the HCA layer, which is followed by 
the macrophages activities that clear the defect and allowing in-growth of new 
cells. Progenitor cells such as mesenchymal stem cells attach themselves onto 
the implant surface, after which the cells are differentiated into osteoblasts; the 
osteoblasts then spawn an extracellular matrix to form bone and the inorganic 
part of the matrix is later crystallized, forming a composite structure with bone 
cells distributed within. The dissolution of a random amorphous network begins 
much earlier than that of a crystalline ceramic therefore the HCA forms more 
quickly on the glass than on synthetic HA [26]. The ability of bioactive glasses 
to accelerate cell growth has been studied and attributed to the release of soluble 
silica and calcium from these glasses, which would affect intracellular 
mechanisms and boost bone regeneration by interacting with the genes. This 
ability is known as the osteoinductivity [39]. The bone regeneration can be 
elevated by the dissolution products in two ways, either they enhance the 
differentiation of stem cells into osteogenic cells or they improve the relevant 
gene transcription of osteogenic cells such as osteoblasts [4-5].  
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The BGs can be made in two ways, conventional melt-quenching or sol-gel 
derived. The conventional way involves the mixing of oxide powders and 
heating up to over 1000 °C for melting, which is followed by quenching in 
water at room temperature. The sol-gel process on the other hand is conducted 
at room temperature; the process begins with hydrolysis of alkoxide precursors, 
which is followed by polycondensation of the colloids which harden into a gel. 
It can take several days to complete the reaction, unless catalysts are introduced 
to speed up the process [66]. Both types of glass have advantages and 
disadvantages depending on the application.  
 
2.4.1 Sol-gel derived BGs 
The sol-gel method is a relatively new way to produce glasses with very high 
levels of chemical homogeneity and surface area as it is nano-porous. Its 
potential was noted and discussed by Hench and West at 1990 [66] and the 
processing protocol to produce a foam using this type of glass was developed by 
Sepulveda and Jones [67] 10 years later.  
 
For sol-gel glasses, a solution that is made of water and nitric acid (HNO3), and 
tetraethyl orthosilicate (TEOS), then calcium nitrate (CaNO3) is added for 
producing glass containing calcium, such as 70S and 58S. The compositions are 
given in Table 2.4. Polycondensation of (-Si-OH) groups continues after 
hydrolysis is complete, beginning the formation of the silicate (-Si-O-Si-) 
network. With the increase in the network connectivity and viscosity a gel is 
eventually formed [34]. 
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Table 2.4   Composition of typical Sol-gel BGs to prepare 250ml of sol 
 58S 70S 100S 
SiO2 (mol%) 58 70 100 
CaO (mol%) 38 30 0 
P2O5 (mol%) 4 0 0 
 
Sol-gel-derived BGs are mesoporous, which means the surface of the glass is 
covered with nano-scaled pores, allowing them a much greater surface area than 
melt-derived BGs. The increase in surface area leads to the increase in the 
number of nucleation sites for HCA layer formation, and the dissolution rate of 
sol-gel BGs is hence much faster than melt-derived BGs of similar composition. 
This means that sol-gel BGs are more bioactive than melt-derived BGs. As a 
matter of fact, because of its high bioactivity, the only ingredients that are 
absolutely essential to include in the composition of sol-gel glasses are SiO2 and 
CaO, whereas in the melt-derived BGs more ingredients need to be introduced 
to increase the sinterability [26, 68]. For melt-derived BGs the mol% of SiO2 
must be less than 60 (preferably less than 55 [69]) otherwise they will lose their 
bioactivity whereas in sol-gel BGs this limit is pushed to 90 mol%. The original 
limited choice of glass compositions that exhibit high osteoproductive 
bioactivity is also widened [69]. 
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Although sol-gel glasses were thought to be homogenously structured 
throughout, Lin et al. has recently discovered otherwise [70]. His work stated 
that the 70S30C glasses traditional sol-gel technique were in fact heterogeneous, 
with a transparent inner core surrounded by an opaque outer shell caused by the 
accumulation of calcium nitrate along the surface during the drying stage of the 
sol-gel process. The calcium-rich outer layer was significantly different to the 
original glass with reduced Si content, much smaller surface area and larger 
nano-pore size. However, the homogeneity could be improved by using a Teflon 
mould as it was highly hydrophobic, which effectively prevented calcium 
deposition on the surface and allowed more time for calcium diffusion and 
distribution; low drying rate (0.1 °Cmin
-1
) would also increase the homogeneity.   
 
The extremely fast dissolution rate of sol-gel glasses was always a concern, 
especially in cases that slower and steadier degradation was required, the 
solution is to use melt-derive BGs. 
 
2.4.2 Melt-derived BGs 
Hench et al. invented the first ever bioactive material - the Bioglass® 45S5 in 
1969 [71], which was a milestone in the history of biomaterials for it integrated 
with the host tissue. Sol-gel BGs are more bioactive than the melt-derived BGs, 
however the fast dissolution rate of sol-gel BGs and the even faster calcium ion 
release rate means their ability to bond to bone is weaker. Bioglass
®
 still 
remains to date, the material that bonds best to the host tissue, and because of its 
superior properties, many attempts have been made since its invention to 
produce 3D porous scaffolds. The only way to produce such scaffold is to sinter 
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the particles, which is problematic for Bioglass
®
 due to its narrow sintering 
window. Glasses have then been developed to overcome such problem, which 
are derived from Bioglass
®
 45S5 with alternation in the composition to expand 
the sintering window but to maintain the bioactivity at the same time, for 
example 13-93 invented by Brink et al. [72] and ICIE 16/ICIE 16M by Elgayar 
and Hill et al. [37]. These glasses and their properties will be examined in 
greater details in Chapter 3. 
 
2.4.3 Summary 
There are two types of bioactive glasses, sol-gel and melt-derived. Sol-gel BGs 
are mesoporous, simple in composition, fast in degradation; whereas 
melt-derived BGs have complex composition systems, include network formers, 
modifiers and intermediates, all playing a different role in affecting the glass 
behavior in terms of sinterbility, bioactivity and thermal and mechanical 
properties. NC is determined by the percentage of BOs in the glass network. A 
NC value of 2 gives the most broken network, i.e. fastest reactivity and 
degradation rate. If the NC is less than 2, i.e. there are more network modifiers 
than network formers, the glass is thermally unstable and devitrifies easily when 
heated beyond Tg. Its dissolution rate is rapid, which leads to cell death and 
fibrous encapsulation [73]. Novel approach in the field is to produce scaffolds 
that are made of bioactive glasses. 
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2.5 Bone Scaffolds and potential scaffold materials 
According to Jones et al. [34], the ideal scaffold should mimic the extracellular 
matrix of the bone tissue both structurally and mechanically. In order to do so it 
needs to act like a template in three dimensions for cell to attach and grow on, 
as well as fulfill the following requirements at the same time:  
 
1) Exhibit a surface that promotes cell adhesion, adsorption of biological 
metabolites. 
2) Influence the genes in the bone generating cells to enable efficient cell 
differentiation and proliferation. 
3) Absorb at the same rate as the tissue is repaired, with degradation products 
that are non-toxic and are able to be excreted by the body easily, for 
example via the respiratory or urinary systems. 
4) Be made from a processing technique that can produce irregular and 
complex shapes to match that of the defect in the bone of the patient. 
5) Has the potential to be commercially producible to the required 
International Standards Organisation (ISO) or Food and Drug 
Administration (FDA) standards.  
 
There is a vast choice of potential scaffold materials, varying from metals to 
ceramics to polymers and composites. Titanium and cobalt-chrome alloys are 
the most popular, which are bioinert materials, but there is a great disadvantage 
considering the formation of fibrous capsule. Despite this, the metals are 
extremely high strength in compression and can withstand cyclic loading. 
However they also have a high Young’s modulus, which will evoke stress 
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shielding after it was implanted, as the result of bone responding to 
environmental stimulation. The outcome is severe, the surrounding bone tissue 
will gradually disappear due to remodeling by the osteoclast activities, exposing 
the implant; and because metals are not biodegradable, the implant will have to 
be taken out and revision surgery required. The brittleness of the ceramic nature 
limits their applicability in bone tissue regeneration as they are easy to fracture 
during stress. Polymers on the other hand are more flexible than ceramics.  
 
Most of the synthetic polymers used in the field are either biologically stable or 
resorbable and some are even osteoconductive [74]. Common FDA approved 
biodegradable polymers are polyesters of poly(lactic acid) (PLA), poly(glycolic 
acid) (PGA) and poly(lactic acid-co-glycolic acid) (PLGA). Scaffolds made 
from synthetic and natural polymers have been investigated extensively for 
bone repair for three reasons [26, 75]: 
 
1) It is easier to process polymers in the shape of a 3D scaffold with a pore 
morphology suitable for tissue engineering applications than it is 
ceramics and glasses 
2) The high tensile properties and high toughness of polymers matches 
with the requirements of bone in load bearing situations, and the 
mechanical properties of polymers can be controlled very easily by 
changing the molecular weight (chain length) of the polymer 
3) Bioresorbable polymers have been used successfully as dissolving 
sutures for many years  
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The techniques used to produce porous networks in these polymers are fiber 
bonding or weaving, solvent casting, particulate salt leaching, phase separation, 
gas foaming, freeze drying and extrusion. Polymer solutions can also be foamed 
to produce an open pore structure by using blowing agents, gas injection, 
supercritical fluid gassing or freeze-drying [26]. 
 
Resorbable polymeric scaffolds have been recently developed with porous 
structures similar to the trabecular bone, but the major disadvantage of these 
kind of scaffolds were that the polymers were not osteoproductive and could not 
bond to bone, moreover polymers have a much lower Young’s modulus than 
bone and therefore could not be applied directly in load bearing applications 
[34]. There were also concerns established over the acidic degradation products 
of such scaffolds. As a result, researchers have shifted their interests into 
polymer-ceramic composites instead, because overall bone is such composite in 
nano-scale. 
 
Oréfice et al. proved that bioactive polymer composites with modified surfaces, 
such as the one investigated in his work, could potentially be osteoproductive 
materials [32]. He suggested that polymer composites, which consisted of a 
bioactive phase, glass-ceramic or ceramic introduced in a high mechanical 
performance polymeric matrix, had potentially the capability of combining 
bioactive behavior with adequate mechanical properties, the combination 
osteoconductivity and the stiffness of the material. This was supported by the 
work of Maquet et al. [76], who discovered the addition of increasing amounts 
of Bioglass
®
 into the polymer foams decreased the pore volume, and improved 
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the mechanical properties of the scaffold.  
 
Despite the similarities of polymer-ceramic composite scaffolds to the bone, 
there are several drawbacks [77-78]. First of all as shown in Figure 2.5, the 
mechanical properties are not as high as expected, in fact it is lower than the 
pure bioactive ceramics scaffolds. This is due to the lack of interface bonding 
strength between the polymer and the ceramic phase. Secondly the dissolution 
rate is different between the two phases, biodegradable polymers usually resorb 
much slower at first than the inorganic phase in the composite structure, but 
once the degradation of polymer starts, it is a self-catalytic and rapid process 
that will lead to the loss of the supporting matrix and failure of the scaffold. 
 
 
Figure 2.5  Elastic modules VS compressive strength of different kinds 
of scaffolds and monoliths [77] 
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2.5.1 Summary 
Many materials can be made into porous scaffold; however none can fully fulfill 
the requirements of an ideal bone scaffold. Metals are bio-inert, and exert stress 
shielding on the surrounding tissue; ceramics are brittle; polymers lack 
osteoconductivity in general and will possibly produce an acidic environment 
through degradation; polymer-ceramic composites have good toughness but are 
quite weak in compression and the difference in dissolution rate in-between the 
two phases are always a concern. Therefore current commercial artificial bone 
grafts are generally bioactive ceramics, usually calcium phosphate based. 
Porous BG foams would potentially give enhanced biological response and 
good control of degradation. If a bioactive glass is used that can be sintered 
without crystallizing, methods used to produce ceramic scaffolds can be applied 
to glasses. 
 
 
 
2.6 Production techniques of porous bioceramic foams  
As reviewed in Secion 2.4, with the modified composition of Bioglass
®
 it can 
be made into porous foams. There are a number of ways to produce porous 
ceramic foams, such as modified freeze casting and slip casting in the early 
stage; later the burning out of a polymeric sponge impregnated with ceramic 
slurry, the replication of polymer foams by impregnation and the gel-cast 
foaming process; the most recent approaches are the sol–gel foaming process 
and rapid prototyping. It is important to choose a suitable method. 
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2.6.1 Freeze casting 
Freeze casting is a simple technique to produce porous complex-shaped 
ceramics [79]. A slurry of ceramic powder and water is frozen (solidification), 
encouraging ice dendrites formation. The dendrites push the powders into the 
inter-dendritic space. The structure is then freeze dried under vacuum conditions, 
with the ice removed by sublimation to avoid the drying stresses and shrinkage 
that might lead to cracks and warping during normal drying. After drying, the 
pre-formed ceramic powder with pores in the size and shape of the dendrites is 
sintered so that the powder densifies into solid walls around the large pores, 
replicating the pure ice dendrites that were formed during the freezing process 
[79-81]. 
 
The pore structure and mechanical properties of the freeze cast foams are solely 
depended on the cooling rate and temperature [82]. Faster cooling rate results in 
higher compressive strength and smaller pore size. The lower the cooling 
temperature, the less interconnected the pore network; rapid cooling may also 
cause aligned, elongated pores [79-80]. Furthermore, the pore size is dependent 
on the slurry concentration and the powder size, which also influences the 
porosity, Yoon et al. successfully produced porous alumina foams with 
interconnect size of >50 µm, porosity of 82% and mechanical strength at 11 
MPa based on 10 vol% alumina slurry [83]. At low ceramic loading, the green 
body collapsed even in the presence of a binder; at high concentrations, the 
body lost the interconnectivity and open porous structure, although this was 
improved by using powder with small particle sizes (2.4 μm) [79]. The strength 
of the scaffold varied from 10 MPa to 60 MPa depending on the cooling rate 
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(<2 °Cmin
-1
 versus >5 °Cmin
-1
) [79].  
 
This technique is limited by the fundamentals of the physics of ice, in particular 
the development of the unavoidable sequence leading to a steady lamellar ice 
front that leads to the formation of two very different architectures to be 
obtained in the final structure (see Figure 2.6a). This poor interconnectivity as 
showing in Figure 2.6b, lead to little interest in a biomedical point of view.  
 
  
Figure 2.6  a) general microstructure of freeze dried samples, the 
dimensions of different zones are depended on the processing conditions, b) 
SEM image of porous HAP samples with 64% porosity parallel to the ice 
front [79] 
 
2.6.2 Polymeric sponge impregnated with ceramic slurry 
This method involves the use of polymeric foam (preferably polyurethane, PU) 
as a template, in order to produce scaffolds with highly ordered pore network, 
high porosity, high interconnectivity and controlled pore size [84-87]. The 
sponge is to be immersed thoroughly into a ceramic slurry followed by 
a) b) 
50μm 
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squeezing the foam to remove excess slurry and drying. The removal of the 
polymeric sponge was achieved by firing the sample at a high temperature 
(sintering temperature of the particles), which would burn off the organic part 
during processing.  
 
The advantage of this technique is the guaranteed high porosity and an accurate 
open pore structure dictated by the polymer sponge template. Figure 2.7a and 
2.7b clearly shows the porous structure of the sponge is maintained through the 
whole process. Chen et al., using Bioglass
®
 [10] and Fu et al., using 13-93 
melt-derived bioactive glass [88] have both applied this technique to create 
porous scaffolds using melt-derived bioactive glasses. However because Chen 
et al. used the Bioglass® composition, the glass crystallized into a glass ceramic. 
They reported the compressive strength of the resulting glass-ceramic scaffolds 
to be very low (0.5 MPa at 86% porosity and 0.1 MPa at 95% porosity). This 
was due to inefficient sintering, because the glass have crystallized before the 
flow between particle was complete, leaving micropores and making hollow 
struts inevitable (Figure 2.8b) [10]. However, the glass was not fully crystallized, 
and a mixture of glass and crystalline regions may cause unpredictable 
properties due to preferential dissolution of the amorphous regions.  
 
Fu et al. achieved dense struts with an impressive strength at 11 ± 1 MPa 
(porosity = 85 ± 2%) because 13-93 was a tailored composition aimed to expand 
the sintering window and was indeed showed much improved sintering. 
However its bioactivity was not ideal as it has a high NC value, for more 
detailed discussion please see Chapter 3.  
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Figure 2.7  Comparison of microstructure of (a) the unfilled PU foam 
and (b) the PU-20 vol% Al2O3 foam [86] 
 
  
Figure 2.8  a) sintered ceramic foam and b) hollow-centered strut [10] 
 
In addition to the problem of hollow struts, this process is difficult to scale up 
for mass production. After the slurry is introduced to the polymer foam, excess 
slurry must be removed and there is no controlled method for doing this. The 
sponges are usually squeezed. If not all the excess is removed, the scaffolds 
suffer from the excess slurry blocking the interconnected pores.  
 
 
 
a) 
a) 
b) 
b) 
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2.6.3 Slip casting foaming process 
Traditionally, slip casting is referred to as liquid clay, where a mixture of clay 
and water is poured into a plaster mold of desired shape and after setting a layer 
clay was formed on the inside cavity of the mould. It is a mass production 
technique and is especially good at producing ceramics with complex shapes. 
Because of its industrial application and easy fabrication steps, it has been 
modified to produce porous foams via slip-casting where the slip was to be 
foamed before pouring into the mold and was immediately set and dried, 
followed by the removal of green body and high temperature firing. 
 
Cyster et al. applied a modified slip casting technique to produce a porous 
hydroxyapatite (HA) scaffold [89], where the HA powder suspension was 
dispersed and agitated by vigorous stirring, followed by the addition of the 
setting agent and the foaming agent, in this case methylcellulose and Tergitol 
TMN10 respectively, into the slurry. The foam was set and dried at 65 °C 
overnight. After the removal of the green body it was fired at 3 °Cmin
-1
 up to 
250 °C, and was held for 30 min to enable complete burnout of the organic 
components. The ceramics were then heated at the same ramp rate up to the 
sintering temperature of 1350 °C and held for 3h followed by cooling to room 
temperature. Figure 2.9 shows SEM images of such scaffold. A very good 
interconnectivity was established at the macroscopic level (Figure 2.9a) and 
Figure 2.9b showed excellent sintering was achieved. 
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Figure 2.9 SEM micrographs showing the a) the pore morphology and b) 
the grain structure of HA scaffolds prepared dispersant concentration of 80 
mgg
-1
 [89] 
 
Their method produced scaffolds with a steady 85% porosity but the 
compressive strengths were relatively low (between 1.07-1.76 MPa). The best 
result was obtained at 80 mgg
-1
 dispersant concentration (85% porosity and 1.76 
MPa). The pore size was between 391-495 µm and the interconnect aperture 
size was between 74 and 133 µm. The major disadvantage of this process is the 
unavoidable partial collapsing of the foam, due to excess dispersant within the 
slip. It is hard to avoid as the porosity is largely dependent on the dispersant 
concentrations.  
 
 
 
 
 
 
1mm 20μm 
a) b) 
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2.6.4 Gel-casting foaming technique 
Gel-casting combines the traditional slip casting with polymer chemistry. It was 
developed in early 90 s by Omatete et al. and Janney et al. as a new technique 
for fabricating dense ceramic foams to replace the conventional way of 
producing light ceramic tile used as construction material, which has many 
functions such as insulation, lightness, machinability and sound/thermal 
insulation [90-91].  
 
The initial gel-casting process was developed by dissolving multifunctional 
acrylate monomers in solvents, water was the most popular choice as it was 
preferred by most ceramics. As a result, water soluble monomers were desired, 
which eventually led to the development of the acrylamide gel system [90, 92]. 
The main monomer has only a single double bond so if it was to polymerize 
alone would result in formation of a linear polymer; whereas the second 
monomer (the crosslinker) has at least 2 double bonds and when the in situ 
polymerization occurs, it forms a crosslinked polymer based gel.  
 
Originally the monomer was acrylamide and the crosslinker was N,N’ – 
methylene bisacrylamide, but the acrylamide was found to be neurotoxic, which 
is a great liability when handling it during the process, and was later replaced by 
the methacrylamide [92-93], a much safer candidate. The crosslinker was not as 
toxic, although it could be replaced by poly(ethylene glycol) dimethacrylate, 
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which has a minimum toxicity and a larger molecular weight [90]. The organic 
part was to be burnt out in order to obtain the final porous ceramic foam hence 
the toxicity was not important in this case. As it is a free radical polymerization, 
an initiator is needed, which in this case is ammonium persulfate (APS). The 
initiator creates free radicals by division of the molecule into two fragments 
along a single bond. A Catalyst is added to speed up the reaction, 
N,N,N’,N’-tetramethylethylene diamine (TEMED) was used. The key step in 
gel-casting is the in situ gelation of a slurry by polymerization of organic 
additives.  
 
Verma et al. produced dense HA by gel-casting [94] while Sepulveda et al. was 
the first person to introduce foaming into the gel-cast process to produce porous 
ceramic foams made alumina [95-96] and HA[97-98], their results suggested 
that gelling time was closely related to the initiation system [95]. To produce a 
porous scaffold, organic monomers are added to a ceramic slurry and the 
mixture is vigorously agitated with the aid of a surfactant, followed by pouring 
into a mold prior immediately prior to in-situ polymerization. The viscosity 
increase due to the progression of the polymerization reaction is critical to allow 
stabilization of the bubbles. As a result, a composite of an organic gelled foam 
containing inorganic powder is formed. The gel is then dried to remove the 
solvent (water), followed by sintering to remove the polymer and densification 
purposes (Figure 2.10).  
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Figure 2.10  Detailed flowchart of the gel-casting foaming process [95] 
 
In Sepulveda’s work, a surfactant (Tergitol TMN10) (Fluka Chemie AG) was 
used to lower the surface tension of a liquid, to maintain the foam structure for a 
short period until it gelled. It played an important role on influencing the foam 
body value, which was closely related to porosity of the foam [97].  
 
A good control of induction time (the time between the addition of reagents and 
the beginning of the polymerization) allowed enough time for bubble 
enlargement and lamella thinning [95-96], and variation in the induction time 
length greatly changed the pore morphology, which was clearly demonstrated in 
Figure 2.11; where the pore sizes in Figure 2.11a, which gelled in 90 seconds, 
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was much smaller than those in 2.11b (gelled in 200 s) however the interconnect 
size seemed not to be affected as much. A long induction time would lead to 
foam collapse and structure weakening, therefore it was the most vital 
parameter in the whole process [99] along with the foam body value, both 
played key roles in determining the final cell size distribution and the strut 
thickness.  
 
In addition, Sepulveda et al. also studied how the persulfate-amine system 
influenced the parameters in the gel-cast foaming system and concluded that the 
induction time and foam body volume was mainly controlled by the initiator 
and catalyst volume [100], which also greatly influenced other minor factors 
such as the temperature, pH and oxygen content. Faster polymerization 
reactions with shorter induction times could be produced at higher and more 
alkaline pHs, higher temperatures, and lower atmosphere oxygen contents. The 
type of surfactant also influenced the microstructure of the foam as shown in 
work done by Fuji et al. [101]. The anionic surfactants performed better than the 
non-ionic ones, and ammonium lauryl sulphate was the best in foaming ability 
and produced alumina foams with highest porosity and pore size distribution. 
Compared to the unfoamed systems, foaming caused a significant change in 
polymerization kinetics, reaction rates were reduced and the systems were more 
sensitive to small temperature variations [96]. There might be cracking at the 
drying stage, which could be reduced by addition of a plasticizer [102-103].  
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The HA foams were characterized and the pore size varied between 20 – 1000 
µm, the porosity was up to 90% and the mechanical strength at 80% porosity 
was 4.4 – 4.7 MPa. The pore size and porosity was directly linked to the 
specimen density.  
 
The slip-cast foaming process in Section 2.5.2 is very similar to this process 
however the slip-casting generates weak green-bodies and the processing time is 
lengthy. Furthermore, the gel-cast foams in Figure 2.11 were much more porous 
at microscopic level than those in Figure 2.9, and there was no problem with 
excess dispersant in the system, in a way gel-cast foaming was an upgraded 
version of the slip-casting foaming process. With the aid of sinterable 
melt-derived bioactive glasses, it is possible to produce scaffolds by this method, 
which is an excellent opportunity for large scale production of high bioactive 
and osteoprodutive material with great potential for clinical application. 
 
Figure 2.11  SEM images of gel-cast foamed HA scaffolds at scaffolds 
gelled with induction times of a) 90s and b) 200s [96] 
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2.6.5 Sol-gel foaming 
Sol-gel BGs can be made into scaffolds simply by introducing air and surfactant 
into the suspension until it gels; this was termed as the sol-gel foaming process. 
It is very important to distinguish gel-cast foaming from the sol-gel foaming 
process for their similarity. They both start with a solution that was hardened 
into a gel at the completion of the process. In gel-casting, a high solid loading (at 
least 50 vol% solid) is required in order to minimize the shrinkage caused by 
drying and to enhance the density of the foam; whereas in sol-gel foaming, the 
solid was usually produced as part of the process in the form of an inorganic gel 
with low solid loading [104]. Figure 2.12 showed the detail of the process [67]. 
The foams produced had a highly uniform pore network as shown in Figure 
2.13. 
 
Figure 2.12  Flow-chart of sol-gel foaming process [105] 
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Figure 2.13 SEM micrograph of a typical pore network produced via sol-gel 
foaming process [106] 
 
One major advantage of sol-gel foamed BG scaffolds is that they have extremely 
high surface area as a result of the mesopores, which will significantly increase 
their bioactivity. A downside to this is that the scaffold may disintegrate long 
before the tissue is regenerated in some applications. The pore distribution was 
homogenous and the porosity was greater than 90%. However these foams 
suffered low mechanical strength, when sintered at 600 °C its compressive 
strength was only 0.36 MPa, but with increasing sintering temperature the sol-gel 
BG scaffolds were able to achieve a compressive strength up to 2.26 MPa (when 
sintered at 800 °C for 2 hrs) [107]. The increase in sintering temperature reduced 
the interconnect size from 122µm at 600 °C to 98 µm at 800 °C as well as risking 
potential partial crystallization (Tc onset of 70S30C sol-gel glass is 845 °C). The 
whole process was rather long: approximately 8 min to gel, 72 hr of aging, 94 hr 
of drying and an additional 14 hours for stabilization prior to sintering.  
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Handling of highly dangerous acid HF is involved as the HF is the catalyst in the 
system; it can be replaced by a less dangerous but stronger HNO3 acid, which is 
still at its early stages of research. 
 
In both the gel-cast foaming and the sol-gel foaming process, the changes in the 
foam structure prior to solidification are important because their influence in the 
final cell size distribution, wall thickness and microstructure of the solid foams 
[108]. 
 
2.6.6 Rapid prototyping (RP) 
This is a relatively new technology, also known as solid freeform fabrication (SFF), 
developed to produce complex shapes directly from a computer generated modal. 
Figure 2.14 shows the remarkable resemblance of the product (2.14b) to the 
computer modal (2.14a). There are many different types of RP techniques each 
with their own benefits and limitations that can be classified into two categories: 
the direct and indirect fabrication methods. The most distinctive advantage of this 
technique is the ability to construct an object with customized macro- and 
micro-structures. The disadvantages are: first, the feasibility of the scaffold is 
dependent on the size of the smallest feature a RP machine can build and hence 
overall resolution size of the machine; secondly, to each RP technique there is a 
very limited choice of materials that are compatible to this specific technique, 
usually bio-inert materials [109-110]. Biodegradable polymers and polymer 
composites are the favorites in research based RP systems for their excellent 
processing abilities; however porous ceramic scaffolds have been produced.   
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Figure 2.14 a) computer design of a polycaprolactone (PCL) scaffold, b) 
the scaffold produced by selective laser sintering rapid prototyping [111] 
 
Seitz et al. and Leukers et al. have applied a 3D printing technique to produce 
hydroxyapatite scaffolds and evaluate their biocompatibility [112-113]; the pore 
size was between 450 – 570 µm with micro pores of 10 – 30 µm but the 
interconnectivity was extremely low; the dynamic cell culture data showed 
formation of continuous cell layer in both inner and outer surface of the scaffold 
with large number of cells in-growth to the HA granules in 7 day’s time. Yang et al. 
has recently developed highly porous HA-TCP meshes by employing extrusion 
freeforming method and achieved a wide range of pore sizes from 50 – 500 µm 
[114]. The use of HA or TCP has limited the bioactivity and the dissolution rate in 
both cases. Rapid prototyping is considered as the next generation of tissue 
engineering for its immense potential in automation and direct organ/cell printing, 
researchers are keen to eliminate its limitations (Iwami et al. had recently 
produced a scaffold that was made with a mixture of cell and hydrogel [115]), 
however the cost remains high compared to the conventional fabrication 
techniques. 
a) b) 
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2.6.7 Summary 
There are many techniques to fabricate porous ceramic foams and are summarized 
in Table 2.5. Gel-cast foaming is the most viable way to produce melt-derived 
bioactive glass scaffolds. 
Table 2.5 Summary of porous ceramic foams fabrication techniques    
Technique 
Interconnect 
size/Pore size 
Porosity Advantage Disadvantage 
Freeze casting 
Depend on 
slurry 
concentration 
>50 µm 
/<200 µm 
Depend on 
slurry 
concentration 
<85% in 
general 
Simple process, 
potential for mass 
production 
Uni-directional 
channels, separate 
architecture in final 
structure, low 
interconnectivity 
Slip-cast 
foaming 
74–133 µm 
/391–495 µm 
85% 
Easy fabrication steps, 
industrial applicable 
Unavoidable partial 
collapsing 
Polymer foam 
replication 
Depend on 
foam 
morphology 
>100 µm 
/<500 µm 
>85% 
Highly ordered pore 
network, 
high porosity, 
high 
interconnectivity, 
controlled pore 
network, 
potential mass 
production ability 
Hollow centered 
struts, partial 
blockage of pores 
Gel-cast 
foaming 
>100 µm 
/20-1000 µm 
Up to 90% 
High 
interconnectivity, 
high porosity, 
simple process, 
potential mass 
productivity 
Possible formation 
of small sulfate 
crystals which is 
discussed in 
Chapter 4 – 5. 
Sol-gel cast 
foaming 
>100 µm 
/10-2000 µm 
With 
mesopores 
2 to 50 nm 
Up to 97% 
High 
interconnectivity, 
high porosity, 
high surface area, 
faster dissolution rate, 
potential mass 
productivity 
In some cases 
dissolution rate is 
faster than tissue 
regeneration rate 
Rapid 
prototyping 
Depend on 
design and 
technique 
chosen 
Depend on 
design and 
technique 
chosen 
Construct object with 
customized macro- 
and micro-structures, 
ability for automation, 
direct organ/cell 
printing 
Limited choice of 
material to specific 
technique, 
resolution 
dependent, 
expensive 
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3 Glass production and characterization 
3.1 Introduction 
Bioglass
®
 cannot be processed due to the narrow sintering window and is therefore 
unable to be sintered and made into scaffolds without crystallization. To overcome 
this problem, more oxides were added into the composition mainly aimed to 
expand the sintering window but maintain the bioactivity at the same time, as well 
as delicate new features to the glass. The first ever melt-derived BG scaffold was 
produced by Fu et al. by applying polymer foam replication technique and 13-93 
BG [88], therefore the glass was included and compared with the others. Elgayar 
and Hill et al. have evaluated the effect of adding alkali and alkali earth oxides 
into the glass composition on the structure of the glass and the degradation rate [37, 
51]. It is from their work that glass compositions were chosen to be applied in this 
project, which are the ICIE 16 and ICIE 16M, a modified version of ICIE 16. 
These glasses have a network connectivity close to 2, which means they have very 
similar chemical structure to Bioglass
®
, but they have a much wider processing 
window and are therefore applicable. 
 
This chapter will go through the glass production process as well as analyzing the 
sintering behaviour of the three glasses by applying Differential Scanning 
Calorimetry (DSC) in Section 3.2 and the result was plotted in Figure 3.1. The 
network connectivity of each glass was also calculated and results summarized in 
Table 3.2. 
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3.2 Materials and methods 
3.2.1 Glass composition 
Table 3.1 shows the compositions of four glasses, ICIE16, ICIE 16M, the original 
Bioglass

 composition and the 13-93 glass (only used as a reference because the 
first melt-derived BG scaffold was made from 13-93 [116] and was not used in 
this project). ICIE16M has the largest number of oxides and 45S5 with the 
simplest composition. 
 
Table 3.1 Glass Compositions 
 
The network connectivity (NC) was calculated using Equation 3.1 (showing 
example of Bioglass
®
), which is a modified version of Equation 2.1. It takes into 
account that phosphorus in the glass network forms Q
0
 orthophosphates (PO4
3-
), 
which has 3 NBOs to each P atom and requires network modifiers to charge 
balance them. The presence of orthophosphates effectively polymerizes the silica 
Compositions 
(mol%) 
Network 
Roles 
45S5 13-93 ICIE 16 ICIE 16M 
SiO2 Former 46.1 54.6 49.46 49.46 
CaO Modifier 26.9 22.1 36.27 27.27 
Na2O Modifier 24.4 6 6.60 6.60 
K2O Modifier --- 7.9 6.60 6.60 
ZnO Intermediate --- --- --- 3 
MgO Intermediate --- 7.7 --- 3 
SrO Modifier --- --- --- 3 
P2O5 Former 2.6 1.7 1.07 1.07 
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network and increase NC [73]. 
 
     
                                            
        
 
(3.1) 
In the presence of network intermediates, there will be two values depending on 
whether to assume the intermediates to behave as network modifiers or formers. In 
the case of 13-93, the equation would be: 
 
     
                                             
              
 
(3.2) 
Assuming the Mg
2+
 as network formers; if assumed as modifiers, it would be: 
 
     
                                            
        
 
(3.3) 
The results are summarized in Table 3.2. 
Table 3.2  The NC values of different glasses  
Glass NC value 
Bioglass
®
 45S5 2.11 
13-93 (assume Mg
2+
 as modifier) 2.59 
13-93 (assume Mg
2+
 as former) 3.00 
ICIE 16 2.13 
ICIE 16M (assume Mg
2+
 & Zn
2+
 as modifiers) 2.13 
ICIE 16M (assume Mg
2+
 & Zn
2+
 as formers) 2.55 
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ICIE 16 and ICIE 16M have similar NC values (2.13) as the Bioglass
®
 (2.12), 
assuming the Mg
2+
 and Zn
2+
 ions are behaving as network modifiers in ICIE 16M. 
In fact this was the reason behind the design of the ICIE 16 and ICIE 16M 
compositions, to create glasses that have the same NC (and therefore similar 
bioactivity) to Bioglass
®
, but a larger sintering window. 13-93 has the largest NC 
values, therefore a slower degradation rate and HCA formation rate is expected for 
13-93 compared to ICIE 16 and ICIE 16M.  
 
3.2.2 Glass production 
All the glasses were produced by weighing and mixing the required amount of the 
analytical grade reagents together in a plastic container, which was well shaken. 
The actual weight of reagents was calculated by first multiplying mol% and 
molecular weight of each reagent, which were then summed up and divided by the 
weight of glass aimed to produce in this batch. Take Bioglass
®
 as an example; for a 
200g pre-fired batch of reagents (46.1% SiO2, 24.4% Na2O, 26.9% CaO and 2.6% 
P2O5, all in mol%), using Na2CO3 and CaCO3 as sources of Na2O and CaO, then 
the first step would be to calculate the mass of each oxide/carbonate :  
 
SiO2: 0.461 × (28.09 + 16.00 × 2)         = 27.70 g 
Na2CO3: 0.244 × (22.99 × 2 + 12.01 + 16.00 × 3)      = 25.86 g 
CaCO3: 0.269 × (40.08 + 12.01 + 16.00 × 3)       = 26.92 g 
P2O5: 0.026 × (30.97 × 2 + 16.00 × 5)        = 3.69 g 
               Σ = 84.17 g 
 
The actual weight of each oxide/carbonate in a 200g batch of reagents would be: 
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SiO2: 200 × 27.70 ÷ 84.17          = 65.82 g 
Na2CO3: 200 × 25.86 ÷ 84.17         = 61.44 g  
CaCO3: 200 × 26.92 ÷ 84.17          = 63.96 g 
P2O5: 200 × 3.69 ÷ 84.17          = 8.77 g 
               Σ = 199.99 g 
 
As the glass was molten, the following reactions would take place: 
CaCO3 → CaO + CO2 
Na2CO3 → Na2O + CO2 
which would reduce the final weight of the glass and should be taken into account.  
 
The mol% of CO2 in the batch would be: 
 
mass of CO2 in CaCO3: 26.92 × 
              
                   
   = 11.84 g 
mass of CO2 in Na2CO3: 25.86 × 
              
                   
   = 10.74 g 
               Σ = 22.58 g 
 
Therefore the actual weight of CO2 in 200g batch of reagents would be: 
200 × 22.58 ÷ 84.17           = 54.65 g 
 
Hence, following melting and allowing for loss of CO2 200g batch of reagents 
would give roughly 146g of Bioglass
®
. 
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The mixture was molten inside a platinum crucible (5 wt% gold and 5 wt% 
rhodium), which was placed in a furnace to heat up to a specific temperature and 
holding time depending on the composition: 1370 °C and held for 1 hour for 
Bioglass
®
; 1420 °C and held for 1.5 hour for ICIE 16; 1400 °C and held for 1.5 
hour for ICIE 16M. The melts were quenched in water and the coarse frit form of 
glass was collected and dried overnight at room temperature. The glass frit was 
ground and then sieved for 2 sets of 7 minutes with 5 minutes of interval 
in-between in order to reduce the particle sizes to <38 µm. The grinding was 
carried on the Glen Creston Ltd. Gy-Ro Mill grinding machine and sieving on the 
Endecotts EFL 2000/1 sieving machine.  
 
The influence of different compositions (ICIE 16, ICIE 16M and Bioglass
®
) on 
sintering behaviour is studied using Differential Scanning Calorimetry (DSC). The 
samples were ramped at 10 °Cmin
-1
 to a final temperature of 950 °C. The modal 
particle sizes (D50 values) in this study were determined using particle size 
analysis and were around 8 µm for each glass. The influence of particle sizes and 
different heating rates on the glasses ICIE 16 and ICIE 16M are also studied by 
DSC. Three particle sizes were analyzed, the frit, >38 µm and <38 µm, the 
samples were each ramped at 20 °Cmin
-1
 to 1000 °C. To evaluate the influence of 
the heating rates, the samples (<38 µm particles) were first heated to 550 °C at 
20 °Cmin
-1
, then to 1000 °C at various heating rates (2 °Cmin
-1
, 5 °Cmin
-1
, 
7.5 °Cmin
-1
, 10 °Cmin
-1
, 20 °Cmin
-1
 and 25 °Cmin
-1
). The activation energies for 
Tg onset, Tc onset and Tp were determined from the different heating rate data by the 
Marotta method in section 3.3.4. 
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Differential Scanning Calorimetry (DSC) 
The DSC is a method commonly used to determine the glass transition 
temperature Tg and the crystallization temperature Tc, hence the sintering window 
of the material, by measuring the variation of the heat flow between the sample 
and the reference material, the reference was alumina in this case. During phase 
transitions, the sample absorbs or releases more heat than the reference material, 
depending on whether the process is endothermic or exothermic, and a graph is 
plotted of the difference in the heat flow. To provide accurate results, the weight of 
the sample and the reference must be the same, for powders it was always 50 mg, 
for frit a single granule that weigh 50mg was tested. A Stanton Redcroft DSC 1500 
with samples and reference in matched platinum crucibles was used.  
 
Particle size analysis 
The size of particles was determined by CILAS 1064 Particle Size Laser Analyzer, 
which gives the modal (most frequent value) and the mean (average value) size of 
the powder. Laser Particle Size Analysis measures the size of particles (powders, 
suspensions and emulsions) using the diffraction and diffusion of a laser beam of 
the light around the particle in its medium. Samples were dispersed in water 
(concentration = 90, measured by machine); 1 drop of Teepol together with 60s of 
ultrasound was applied to help further dispersion. Each size (<38 µm and >38 µm) 
was repeated for 5 times and an average value was taken. 
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3.3 Results and discussion 
3.3.1 Influence of composition 
Figure 3.1 shows the DSC traces of the 45S5 Bioglass

, ICIE 16 and ICIE 16M 
(particle size <38 µm). Compared to Bioglass

, Tg onset increased from just over 
500 °C to 575 °C for ICIE 16 and 550 °C for ICIE 16M; the onset temperature for 
crystallization (Tc onset) increased from 575 °C for Bioglass
®
 to around 750 °C 
whereas the Tp (peak crystallization temperature) increased from 600 °C to over 
775 °C for both ICIE 16 and ICIE 16M. The sintering window is defined as Tc onset 
– Tg onset. For ICIE 16 it was 175 °C and 200 °C for ICIE 16M, compared to less 
than 75 °C for Bioglass

. The DSC data indicates that the ICIE 16 and ICIE 16M 
glasses could be sintered without crystallization at temperatures below 750 °C.  
 
Figure 3.1 DSC traces of the 45S5 Bioglass

, ICIE 16 and ICIE 16M
1
 
                                                          
1
 Data provided by Donovan Nightingale 
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 There was something interesting going on in Figure 3.1, Bioglass
®
 only showed 
one Tg whereas ICIEI 16 and ICIE 16M showed two, but all three were showing 
two Tcs. In section 2.4 the role of each component in BG was discussed and P was 
considered to be present in the glass structure as orthophosphate form, which 
cannot be linked to the silica network (see Figure 2.4 for illustration). This means 
that all three glasses in Figure 3.1 were two phase systems and it was expected to 
see two Tgs and two Tcs, however Bioglass
®
 would have crystallized shortly after 
the first Tg so the second Tg was overwhelmed by the magnitude the first Tc, which 
was the reason that Bioglass
®
 only showed one Tg but two Tcs. There was only 
1.07 ml% P in the compositions of ICIE 16 and ICIE 16M which means the 
orthophosphate glass phase would be reasonably small, thus the second Tg would 
be rather weak and difficult to detect, however it was not the case in Figure 3.1. 
Because Tg represents the change in heat capacity, as the glass undergoes sintering 
the fine particles will fuse together and form a monolith, which will increase the 
heat capacity by a great amount, therefore the decline in the base line slope before 
Tc onset was indicating that sintering was taking place rather than a second Tg. 
 
3.3.2 Influence of particle sizes
2
 
 When powders undergo sintering, crystallization if any, will occur in forms of 
surface crystallization, where the particle size is the critical factor, different 
particles crystallize to different degrees. The DSC traces of ICIE 16 (Figure 3.2a) 
and ICIE 16M (Figure 3.2b) in different particle sizes shows exactly how the 
particle sizes effected the sintering parameters such as T g onset and Tc onset, and the 
data is summarized in Table 3.3. Overall, the Tc onset increased as the particle size 
                                                          
2
 Data provide by Hannah Choi 
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increased for both glasses, which was expected; because as the particle size 
becomes smaller, surface energy grows higher and the materials is more prone to 
surface crystallization, which means crystallization will occur at a lower 
temperature. The Tg onset on the other hand did not show any significant change, the 
reason being that the size of the particle would not affect the heat capacity. There 
was a notable decline around 520 °C (500 °C for ICIE 16M) on the <38 µm trace, 
the temperature was too small for Tg therefore it was suspected to be an artifact. 
The magnitude of Tc and Tg generally increased with larger particle size as a result 
of reduced sintering. The sintering widow of ICIE 16M was generally greater than 
ICIE 16 at all sizes, indicating better processing abilities. 
 
 
Figure 3.2 DSC traces of a) ICIE 16 and b) ICIE 16M in different particle sizes  
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3.3.3 Influence of heating rates
2
 
 Tg onset, Tc onset and Tp of different heating rates of ICIE 16 and ICIE 16M were 
determined according to the way shown in Figure 3.3a and Figure 3.3b but on a 
full sized diagram. Note that there was a change in the baseline slope around 
550 °C, this was caused by the changing of heating rate and should not be counted 
towards the result. In general, Tg onset, Tc onset and Tp all decreased with decreasing 
heating rate, at higher heating rates (25 °Cmin
-1
 and 20 °Cmin
-1
) there were two 
Tgs and the magnitude of Tc was greater than slower heating rates, this was 
because higher heating rates allowed less time for sintering to take place. As a 
result it was impossible to measure Tg2 onset from this data. 
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Figure 3.3  DSC traces of different sintering rates on a) ICIE 16 and b) 
ICIE 16M (<38 µm)  
 
 Table 3.3  Tg onset, Tc onset and Tp values of ICIE 16 and 16M against 
different heating rates 
 ICIE 16 ICIE 16M 
Heating rate 
(°Cmin
-1
) 
Tg onset 
(K) 
Tc onset 
(K) 
Tp 
(K) 
Tg onset 
(K) 
Tc onset 
(K) 
Tp 
(K) 
2 850 1016 1033 --- --- --- 
5 861 1039 1068 839 1078 1116 
7.5 863 1048 1083 849 1084 1129 
10 863 1059 1096 853 1094 1140 
20 870 1082 1123 860 1105 1171 
25 873 1086 1137 868 1128 1178 
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3.3.4 Determining the activation energies (Ea) and sintering window 
Crystallization is a combination of nucleation and crystal growth processes; it is 
temperature dependant and its Ea can be determined by heating the sample at 
different rates. The Marotta method [117], which is based on the relationship 
between heating rate and the crystallization temperature, it takes into account 
surface crystallization only and is affected by both nucleation and growth 
processes. The equation employed is given as below: 
  
 
 
  
  
   
 
(3.1) 
where T is the heating rate, Ea is the activation energy, R is the gas constant (8.314 
JK
-1
mol
-1
) and Tp is the peak crystallization temperature. A graph was plotted with 
ln heating rate against 1/T (data from Table 3.3), from which Ea could be 
determined by multiplying the negative value of gas constant with the gradient of 
the trend line from Figure 3.4a for ICIE 16 and Figure 3.4b for ICIE 16M, and the 
results were summarized in Table 3.4. In order to define the sintering window, the 
extrapolated temperature of 1/Tg onset and 1/Tc onset at 0 Kmin
-1
 ln heat rate was the 
minimum and the maximum sintering temperature respectively, the values were 
recorded in Table 3.5 and the difference between them would be the sintering 
window.  
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Figure 3.4  Plots of ln heat rate against 1/Tg onset, 1/Tc onset and 1/Tp of a) 
ICIE 16 and b) ICIE 16M, and the extrapolation of 1/Tg onset and 1/Tc onset 
at 0Kmin
-1
 ln heating rate 
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 Table 3.4  Summary of Ea for Tg onset, Tc onset and Tp derived from Figure 
3.4 using the Marotta method 
 Ea (kJmol
-1
) for 
 Tg onset Tc onset Tp 
ICIE 16 703 321 241 
ICIE 16M 363 328 274 
 
  
 The Ea of ICIE 16M for Tp and Tc onset is greater than that of ICIE 16, which again 
confirms ICIE 16M is better than ICIE 16 in terms of suppressing crystallization. 
The lower Ea Tg onset value of ICIE 16M means its viscous flow and sintering 
occurs more readily compared to ICIE 16.  
 
  Table 3.5  Summary of Tg onset, Tc onset and Tp of ICIE 16 and ICIE 16M 
derived from the extrapolated data 
 Tg onset (°C) Tc onset (°C) Tp (°C) 
ICIE 16 572 723 735 
ICIE 16M 542 756 785 
 
  
As expected, ICIE 16M had a larger working range (209 °C) than ICIE 16 
(151 °C), which means the ICIE 16M is better at suppressing crystallization than 
ICIE 16. 
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3.4 Summary 
The network connectivity value was the same for ICIE 16 and Bioglass
®
 (both at 
2.1). It was also the same for ICIE 16M if assuming the Mg
2+
 and Zn
2+
 ions were 
behaving as network modifiers. If they were to behave as network formers, the NC 
value of ICIE 16M would be 2.7, leading to a slower degradation and HCA 
formation rate. On DSC graphs there were two subtle Tgs on the traces of ICIE 16 
and ICIE 16M but not Bioglass
®
, this was because Bioglass® had crystallized 
shortly after the first Tg when the other two glasses had undergone sintering; 
meanwhile all three glasses showed two Tcs, which was an indication of 
two-phased system (an amorphous silica phase and an orthophosphate phase). 
Increase in particle size and heating rate would suppress sintering and enhance the 
DSC trace. The sintering windows of ICIE 16 and ICIE 16M were 175 ºC and 
200 °C respectively, which were both much wider than Bioglass
®
 (75 °C). For 
both ICIE glasses, particle size did not affect Tc onset but the Tc onset, which 
increased as particle size grew larger. The Tc onset – Tg onset value was greater for 
ICIE 16M (209 °C) than ICIE 16 (151 °C), which represented a wider sintering 
window. The activation energy of Tc onset and Tp was higher for ICIE 16M (328 and 
274 kJmol
-1
) than ICIE 16 (321 and 241 kJmol
-1
), which means 16M was better at 
suppressing crystallization; the Ea of Tg onset however was lower for ICIE 16M 
(363 kJmol
-1
) than of ICIE 16 (703 kJmol
-1
), indicating 16M was better at viscous 
flow and would sinter more readily than ICIE 16. ICIE 16 could be sintered 
without crystallization at any temperatures below 723 °C, which for ICIE 16M it 
was 756 °C. All results indicated that ICIE 16M was better at sintering than ICIE 
16. 
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4 Identifying and optimizing of the standard protocol of the 
gel-cast foaming process  
4.1 Introduction 
Gel-cast foaming process was introduced by Sepulveda et al. to produce porous 
HA foams but was never applied to melt-derived bioactive glasses. The aim of this 
chapter is therefore to develop a protocol in producing such scaffolds. Pilot studies 
were carried out by Cichy et al. [118] on ICIE 16M (<53 µm) glasses where two 
gelling systems were analyzed: the methyl methacrylate (MMA) as monomer with 
benzoyl peroxide as initiator, N,N-dimethyl-p-toluidine as catalyst and ethylene 
glycol dimethacrylate as cross-linker; the other with methacrylamide as monomer, 
ammonium persulfate (APS) as initiator, N,N,N’,N’-tetramethylethylene diamine 
(TEMED) as catalyst and N,N’-methylenebisacrylamide as cross-linker. Moreover, 
the influence of various types of surfactants (Tergitol TMN10, Teepol and Triton 
X100) on the gelling system was investigated. According to the result, the MMA 
gelling system failed to foam or gel and was therefore discarded. Out of the three 
surfactants, Triton X100 achieved the best foaming ability and was therefore 
chosen to be incorporated into the methacrylamide gelling system instead of the 
Tergitol TMN10, which was originally used by Sepulveda et al.. The scaffolds 
obtained was 72% porous with small (<100 µm) pores and did not sinter well. 
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Necessary changes were made to the protocol that Cichy et al. used, it was found 
that in order to create an interconnected pore network suitable for bone 
regeneration, maintaining a reasonable volume of foam during agitation (e.g. 130 
ml from an original suspension of 40 ml) until polymerization occurs (e.g. 90 
seconds) was the key. This is because too high a foam volume would result in very 
large pores and low mechanical strength whereas too little would give insufficient 
pore and interconnect size. Therefore to investigate the effect of process variables 
on the foam structure, the effect of the process variables on foam body volume 
was investigated initially, before relating it to pore size. The gelation time is 
critical because a rapid gelling time was not sufficient for the foam to develop but 
with too much time in agitation the foam collapsed and lost its stability. How to 
determine the gelling time and the foam body volume is explained in section 4.2. 
As shown in Table 4.1, there are 8 variables to consider. From pilot tests, it was 
concluded that the type of the glass did not affect the gelling time and the foam 
body. The monomer to cross-linker ratio was set to be 2:1. Water, catalyst and 
initiator content, on the other hand, played a significant role.  
 
The aim of this study was to devise a processing protocol for the production of 
scaffolds suitable for bone regeneration and to optimize the structure for maximum 
mechanical strength while maintaining an open porous network. 
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Table 4.1 Gel-cast foaming process variables 
Order Components Role 
1 Glass powder  Material 
2 Ultra-purified water Medium 
3 Methacrylamide Monomer 
4 N,N’-methylene bisacrylamide Crosslinker 
5 APS solution Initiator 
6 Dispex Dispersant 
7 Triton X100 Surfactant 
8 TEMED Catalyst 
 
4.2 Experimental 
As shown in Figure 4.1, the first step of the process was to mix the glass powder 
with deionised (18) water, the monomer (acrylamide) and the cross linker (N, 
N’-methylene bisacrylamide) to produce a slurry. The dispersant (Dispex) was 
added to help further dispersion of glass powder in the solution. The mixture was 
then vigorously agitated (Kenwood hand mixer) to produce a foam with the aid of 
the surfactant (Triton X100). Polymerization was activated by the addition of the 
initiator (ammonium persulfate solution with a concentration of 0.52 gml
-1
) and 
the catalyst (tetramethylethylene diamine), which reacted with each other releasing 
a free radical particle. This free radical then reacted with both the acrylamide and 
the N, N’-methylene bisacrylamide, forming a polymer network. Gelling time was 
recorded from the moment the catalyst was introduced to the suspension until the 
moment it had turned into a gel, which was when poured the suspension would not 
flow, typically in about one and half minute. After 50 seconds the whisks were 
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taken out, the agitation was paused and the plastic beaker was set down to take 
measure of the foam body at the side of the beaker, however once the readings 
were taken agitation must be resumed as soon as possible to avoid foam collapsing. 
Immediately (~2 or 3 seconds) prior to the gelation, the foam was cast into moulds, 
in this case 60ml screw-cap polypropylene containers, caps must be screwed on to 
avoid cracking on the surface of the gel that was induced by rapid cooling. The 
moulds were set in room temperature for around half an hour allowing the pore 
structure to be stabilized by the completion of gelation; they were then dried and 
sintered to burn out the organic green body, leaving the porous glass network. 
 
 
Figure 4.1 Flow-chart of the gel-cast foaming process 
 
After many failed attempts, a base protocol was devised from the one that worked 
the best for Cichy et al. [118], which did not work when it was repeated; the detail 
is shown in Table 4.2. It can be noted that certain ratio of components in the slurry 
was changed for the protocol to become operable. 
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 Table 4.2 The Cichy E19 protocol and the base protocol derived from it 
 E19 Base Protocol 
Glass powder (g) 7 14 
Water (ml) 5 20 
Methacrylamide (g) 1.5 6 
N,N’-methylene bisacrylamide (g) 0.5 3 
APS solution (ml) 1 4 
Dispex 2 drops 2 drops 
Triton X100 (ml) 0.05 0.1 
TEMED (,ml) 2 6 
 
 
Apart from the monomer (6 g), the crosslinker (3 g), the dispersant (2 drops) and 
the surfactant (0.1 ml), which were all kept constant throughout, the influence of 
all other components on both the gelling time and the foam body was investigated 
systematically. These components were verified unsystematically and the values 
chosen were the minimum amount of each component needed to be present in the 
system to function. Using the base protocol the effect of varying water content (10 
ml, 12 ml, 14 ml, 16ml, 18 ml, 20 ml, 22 ml, 26 ml, 28 ml and 30 ml) and catalyst 
content (3 ml, 4 ml, 5 ml and 6 ml) were investigated. The glass powder loading in 
the slurry (10 g, 14 g, 20 g and 30 g) in 20 ml water with 3 ml catalyst was then 
investigated. APS is highly hygroscopic (absorb or adsorb water from the 
environment), it dissolves in water very easily, but by doing so it loses its 
reactivity drastically. Therefore the effect of initiator freshness was also evaluated.  
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As a result of this study, the base protocol was modified to: 20 g glass, 18 ml 
water, 6 g monomer, 3 g crosslinker, 4 ml catalyst, 4 ml initiator, 2 drops of 
dispersant and 0.1 ml surfactant. The effect of initiator content (1 ml, 2 ml, 3 ml, 4 
ml, 5 ml, 6 ml and 7 ml) on gelling time and foam body volume was then verified. 
Each data point was repeated at least 3 times to test the reproducibility of the 
experiments. 
 
4.3 Results and discussion 
4.3.1 Effect of Water 
The amount of water in the system had a large impact on the gelling time and foam 
body. Figure 4.2 shows that as the water content increased from 10 to 30 ml, the 
average gelling time also increased from 50 to 114 seconds (127% increase), and 
the foam body increased from 50 to 192 ml (283% increase) respectively. Too little 
water significantly shortens the gelling time and it does not give a sufficient foam 
body volume, on the other hand too much water would weaken the structure after 
gelation, which would collapse after drying. This means that somewhere in the 
middle (18 to 20 ml) was the sensible choice. Error bars were largest at 18 ml, 
which was because it has been used for most of the times, and the freshness of 
APS solution was not taken into account until later. 
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Figure 4.2 Influence of water content on the gelling time and the foam body  
4.3.2 Effect of Catalyst 
The effect of catalyst concentration was different to water (Figure 4.3). As catalyst 
content increased from 3 to 4 ml, there was a sharp decline in the gelling time 
from 126 to 96 s. The gelation time was approximately constant (83 s) as the 
catalyst content increased from 5 to 6 ml. The foam volume reduced gradually 
from 170 to 167 ml as the catalyst content increased from 3 to 4 ml and decreased 
sharply (from 158 to 110 ml) as the catalyst volume increased from 5 to 6 ml, even 
though the gelling time was approximately the same at these two data points. The 
ideal foam body was around 130 ml and an ideal gelling time for producing a 
stable foam body was around 90 s, so 18-22 ml of water was suitable for the 
process. 18 ml of water and 4 ml of catalyst were chosen to be the standard 
quantities. 
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Figure 4.3 Influence of catalyst content on the gelling time and foam body  
 
4.3.3 Effect of Initiator 
As the initiator content increased from 1 to 7 ml, the gelling time decreased (182 
to 51 s) and the foam body volume increased from 130 to 170 ml (Figure 4.4). The 
relationship was not linear over the range of concentrations used: as initiator 
content increased from 1 to 3 ml there was a sharp decline in gelling time from 
182 to 84 s whilst the foam volume changed little, reducing from 130 to 124 ml. 
Then, as initiator content increased from 3 to 7 ml the gelation time decreased 
more slowly from 84 to 51 s and the relationship was approximately linear. The 
foam volume increased approximately linearly from 124 to 170 ml.  
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Figure 4.4 Influence of initiator content on the gelling time and foam body  
 
In addition to the above components, the vitality of the initiator (APS) solution 
influenced the gelling time and the foam body volume of the suspension 
significantly. After mixing the APS powder with distilled water, it had to be left for 
at least 3 h before it could be used, otherwise the suspension would not foam at all, 
even though the gelling time was not affected. The solution became less reactive 
as time passed; therefore it was remade after 1 week. If the solution was left more 
than 1 week the gelling time was significantly prolonged. 
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A side effect of using APS as the initiator was that crystallites were present in the 
glass after sintering, these were not due to crystallization of the glass, but were 
identified by EDX (Figure 4.5) and XRD to be potassium sodium sulfate 
(K3Na(SO4)2) (01-074-0398), Figure 4.6 shows a matched pattern of the XRD 
trace. Due to the glass being in contact with water during the process, sodium and 
potassium ions were dissolved from the glass in an ion exchange mechanism. The 
ions reacted with the sulfate, which was a by-product of the initiator (APS), 
causing nucleation of crystals on the surface of the glass particles. As the scaffold 
was sintered, the organic part was burnt out, leaving glass particles stacked in a 
porous glass structure, which then fused together as the temperature increased 
further. The crystals were therefore incorporated into the glass. Although the 
gelling time was short (90 s), the glass remained in contact with water during 
drying. Small amounts of K3Na(SO4)2 may not affect biological properties and its 
dissolution behaviour was studied in Chapter 6.3.3.2, but methods to eliminate its 
formation were devised regardless. 
 
Figure 4.5 EDX analysis of a crystalline and the glass strut 
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Figure 4.6 Matched pattern on the XRD trace of the scaffold after sintering 
 
The options were to reduce the time that the glass was in contact with water 
(Chapter 5) or to reduce the amount of initiator used in the process. An optimised 
process may involve taking both of these measures. Figure 4.7a to 4.7d show that 
as the initiator volume increased from 1 to 4 ml, the crystallization of the 
K3Na(SO4)2 was suppressed as there was less sulfate available. No crystallites 
were observed on scaffolds made with 1 ml APS, but with this little amount it was 
barely capable of gelling and the structure was rather broken as showing in Figure 
4.7a. Therefore 2 ml was the optimum amount of initiator to be applied in the 
gel-casting process. 
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Figure 4.7 SEM images of using a) 1 ml, b) 2 ml, c) 3 ml and d) 4 ml of 
initiator in the gel-cast foaming process 
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4.4 Summary 
An optimal protocol for the gel-cast foaming of ICIE 16 was therefore set up. The 
standard formula of the process was: 20 g glass powder, 18 ml water, 6 g 
methacrylamide (monomer), 3 g N,N’-methylene bisacrylamide (cross-linker), 2 
ml ammonium persulfate solution (initiator), 0.1 ml Triton X (surfactant), 4 ml 
tetramethylethylene diamine (TEMED) (catalyst). The vitality of the APS solution 
is very important, it must be left to stand for at least 3 hours prior to application to 
prevent non-foamed suspension, and it must be freshly prepared every time as its 
reactivity is inversely proportional to the time. In addition, potassium sodium 
sulfate crystals were found on the surface of the foam after sintering, which was 
caused by the complex reaction between water, glass and sulphur in APS. Such 
crystallization could be controlled by reducing initiator content in the slurry. 
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5 Optimizing the drying and sintering program 
5.1 Introduction 
After gelation, the foam is a composite of bioactive glass particles in a polymer 
matrix (Figure 5.1). They must be dried and a thermal process had to be devised to 
remove the polymer without causing collapse of the structure and to allow the 
particles to sinter. Once the polymer is removed, the glass particles are effectively 
balancing on each other, a very careful thermal processing regime is therefore 
required to induce sintering without causing excess flow of the glass and collapse 
of the structure or crystallization. The thermal process also had to be optimized to 
inhibit possible potassium sodium sulfate formation. 
 
Figure 5.1  SEM image a) the whole structure and b) the surface of the 
dried foam (unsintered) 
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Provided with a wide sintering window as discussed in Chapter 3, it was difficult 
to predict at which conditions the scaffold best sinters. Sintering is affected by 
many factors, such as the particle size, the packing between particles, the ramp 
rate, the holding time, the sintering environment and temperature. It is thought the 
smaller the particle size and the higher the specific surface area, the closer the 
particles are packed together, the better the sintering. The ramp rate is important 
because high ramp rate results in rapid burn out of the polymer and collapse of the 
whole structure. The holding time and temperature are critical factors, if the 
holding time is too long or too high the temperature, the material flows too much 
and destroys the structure of the scaffold; but if too short or too low, the material 
underflows, i.e. the particles will not fuse together, which will also destroy the 
structure. Hence it is very important to find the suitable condition to sinter the 
scaffold, varying only one factor at a time.  
 
The drying and the sintering temperatures were verified as it played an important 
role in the crystallization of the glass and in potassium sodium sulfate 
crystallization, which will be discussed in Chapter 5.3. The aim of this chapter was 
to find out the optimum drying and sintering temperature for gel-cast ICIE 16 and 
ICIE 16M glasses by employing DSC, SEM and XRD techniques.  
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5.2 Experimental 
5.2.1 Determining the suitable sintering programme  
As shown in Figure 5.2, a two stage sintering program was followed where the 
samples were first fired and held at a lower temperature in order to burn off the 
polymer in the network; which was then fired and held at a higher temperature 
close to Tc in order to permit the fusion of glass particles, and the sintering process 
was complete after the samples were furnace cooled to room temperature.  
Figure 5.2  Schematic sintering program 
 
Differential Scanning Calorimetry (DSC) 
To investigate how the gel-cast structure behaved during sintering, a DSC-TGA 
test was carried out on a gelled foam (dried at 100 °C and unsintered) at 2 °Cmin
-1
 
and the result was shown as Figure 5.3 that showed not only the variation of heat 
flux but the weight loss as the temperature increased. From the figure the 1
st
 
holding temperature was chosen which is at where the first exotherm was at peak 
(approximately 350 °C) and thus a sintering program was derived.  
  
90 
Fine ICIE 16 glass powder (<38 µm) and ground gel-cast foam (dried at 125 °C 
and unsintered) made with 1CIE 16 glass were sintered using this program on the 
DSC, with an extension at the end of the program to ramp to 1000 °C at 
20 °Cmin
-1
, to investigate whether the gel-casting process affected the glass 
properties including the glass transition and crystallization temperature.  
 
5.2.2 Influence of particle size 
The effect of particle size was observed by applying the optimum protocol to two 
particle size ranges, which were collected after sieving the ground frit with a 38 
µm sieve: >38 µm and <38 µm. The tests were carried out using CILAS 1064 
Particle Size Laser Analyzer. Each data point was repeated 5 times in order to 
obtain a modal particle size value. The results were summarized in Table 5.1. 
Images of scaffolds made with different particle sizes were taken by employing 
SEM (Figure 5.4). 
 
5.2.3 Verifying drying and sintering temperature 
The effects of drying and sintering temperature were then assessed. The gelled 
foams were dried at different temperatures: 100 °C, 125 °C and 150 °C, followed 
by a two stage sintering programme where the temperature was ramped to 350 °C 
at 2 °Cmin
-1
 and held for 1 h; then ramped again to either 680 °C, 700 °C, 710 °C 
or 730 °C at 2 °Cmin
-1
 and held for 1 h. The results were analyzed by using SEM 
and XRD. 
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Scanning Electron Microscopy (SEM) 
SEM is a powerful imagining method to view the sample surface and particle 
arrangements at great detail. The disadvantage of SEM is being destructive as well 
as the ability to produce 2D images only. JEOL JSM-5610 and JEOL-6500F LEO 
FEG SEM were used to obtain high resolution imaging and carry out 
Energy-dispersive X-ray Spectroscopy (EDS or EDX) analysis, which was aimed 
to find out the composition of the area of interest. EDX is a fundamental analytical 
technique to determine the composition of a specimen in elemental level. For 
JEOL JSM-5610 SEM, samples were cut into 2×2 mm pieces using small surgical 
scalpel blades and were coated with gold in EMITECH K550 Gold Coater, 
operating time 3 min at 30 mA. For the JEOL-6500F LEO FEG SEM, samples 
were cut into the same size but were coated with chromium, operating time 1 min 
at 65 mA. To analyze sample by JEOL JSM-5610 SEM, the working distance was 
kept as 20 mm and the operating voltage vary between 11 to 20 kV, magnification 
was kept at ×100 except for Figure 5.5, where it was enlarged to ×500 to allow 
closer inspection of the structure. 
 
X-ray Diffraction Spectroscopy (XRD) 
The scaffolds were ground into fine powders and were analyzed by XRD (Philips 
PW 1729 X-ray generator and PW1710 control system with Cu k-α source, 
operating at 40 kV and 40 mA, data was collected between 2θ angles at 5 to 70° at 
an increment of 0.04°). Diffraction patterns were obtained to evaluate the degree 
of crystallinity. The diffraction patterns were matched using the PANalytical 
X’Pert HighScore Plus (version 2.2b) software program. 
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5.3 Results and discussion 
5.3.1 Determining the suitable sintering programme  
In Figure 5.3, the DSC trace shows that there is a large exotherm at 375 °C 
followed by a larger one at 560 °C. The TGA trace shows constant weight loss 
until it reached a constant at 580 °C. Originally it was thought that the two 
exotherms represented the burning off of the polymer network and the oxidizing of 
remaining carbon inside the scaffold structure, and a preferential sintering program 
was drawn according to the data, starting with ramping to 350 °C at 2 °Cmin
-1
 and 
held there for 1 h, followed by ramping again at 2 °Cmin
-1
 to 730 °C and held for 
another hour. The first holding temperature was lowered to 350 °C from 375 ˚C 
given the long holding time. Sintering at higher temperature for a short period of 
time works the same as to sintering at lower temperature for a longer time. The 
sintering temperature was chosen based on the DSC data obtained from the 
as-melt-quenched glasses Figure 3.1, where both glasses were thought to be 
capable of undergoing sintering at any temperatures below 750 °C. However in 
practice there was large scale of crystallization when the samples were sintered at 
730 °C, which is likely due to the presence of water and the slow ramp rate 
reducing the onset crystallization temperature.  
 
Despite the disadvantage, slow ramp rate was needed as it would provide a 
relatively steady environment for polymer burn off and particle fusion. Thus, the 
sintering temperature had to be reduced to minimize crystallization of the glass. 
The aim of this chapter was to optimise the sintering temperature (too low would 
not sinter the particles efficiently). 
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Figure 5.3 DSC-TGA trace of ICIE 16 gel-cast scaffold up to 700 °C 
(unsintered) 
 
In Figure 5.4, despite the small fluctuation in the baseline that was present due to 
the slow heating rate, there was a distinctive double exothermic peak (marked 
point A and B) at 292 °C and 324 °C. There was another large peak (C) at 429 °C. 
None of these were present in the trace for the as-melt-quenched glass powder. 
The exotherms represented the burning out of the polymer network (292 °C and 
324 °C) and the crystallization of the potassium sodium sulfate (429 C). Above 
429 C, both traces kept the baseline readings until 700 °C was reached where 
there was a small dip (D), which was due to the sudden change in the ramp rate 
(from 2 °Cmin
-1
 to 20 °Cmi
-1
). The Tg was designated by a small endotherm in the 
fine glass powder trace around 650 °C whereas this endotherm occurred at 675 °C 
for the gel-cast glass powder. The Tc was marked by a third exothermic peak, 
which occurred around 820 °C (E) for the gel-cast glass powder and at 780 °C (F) 
for the fine glass powder.  
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The DSC results suggested that the gel-casting process actually helped postponing 
the crystallization of the glass and therefore it should not crystallize when sintered 
at 700 °C. However, the glasses crystallised when the gel-cast foams were sintered 
at 750 C (Section 5.3.3). This is again thought to be due to the presence of water 
at the early stage of the process, which assisted the nucleation of crystals on the 
surface of glass [119-122].  
 
 
Figure 5.4 DSC of ICIE 16 glass powder (<38 µm) and ground gel-cast foam 
(unsintered) 
 
 
5.3.2 Influence of particle size on the scaffold structure 
The size of the glass particles played a critical role on sintering. From Table 5.1, 
the mean values were deduced and the most important value is the D50 of each 
type of the powder, which is the modal size distribution value.  
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Table 5.1 Particle size analysis data for ICIE 16 and ICIE 16M glass 
powders 
 
D10 mean 
(µm) 
standard 
deviation 
D50 mean 
(µm) 
standard 
deviation 
D90 mean 
(µm) 
standard 
deviation 
ICIE 16 <38 µm 1.23 0.03 7.70 0.68 32.84 5.38 
ICIE 16 >38 µm 41.52 1.71 74.19 7.60 124.84 10.5 
ICIE 16M <38 µm 1.19 0.19 6.14 0.56 22.65 2.83 
ICIE 16M >38 µm 40.48 2.88 73.58 1.81 129.29 2.35 
 
 
When >38 µm particles were used, sintering was not completed at 700 °C 
(optimum sintering temperature, see Section 5.3.4 for more details) (Figure 5.5a). 
The foam struts were not fully dense and consisted of large particles embedded in 
a sea of smaller particles, which were loosely attached to one another, and the 
scaffold structure was fragile. The pore network collapsed during sintering.  
 
When <38 µm particles were used, the structure was intact and the scaffold was 
well sintered (Figure 5.5b). Particle packing and stacking during sintering was 
better for the <38 µm particles. The smaller particles have a higher specific surface 
area and a greater driving force for sintering and must be used in order to allow 
efficient sintering at 700 °C. However, smaller particles have a larger surface area 
for crystal nucleation that are also likely to promote crystallization at lower 
temperatures, which means the Tc is reduced and the sintering window shortened, 
but only to a small extent.  
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Figure 5.5 SEM images of scaffolds, sintered at 700 C, made with a) >38 µm 
and b) < 38 µm glass particles 
 
 
 
a) 
b) 
  
97 
5.3.3 Influence of the drying temperature 
Attempts were made to eliminate the K3Na(SO4)2 formation by reducing the 
amount of water present and the amount of time the water was in contact with the 
glass, by increasing the drying temperature. Water could not be removed from the 
initial stages of the gel-cast foaming as the surfactant can only stabilise bubbles in 
the presence of water and surfactants rarely works well with other mediums such 
as ethanol. Figure 5.6 shows SEM micrographs of the surface for ICIE 16 
scaffolds sintered at 700 ºC but dried at 100 °C, 125 °C and 150 °C. The size of 
the K3Na(SO4)2 crystals was significantly reduced from ~70 µm when dried at 
100 °C (Figure 5.6a) to ~20 µm by drying at 150 °C (Figure 5.6c). In theory 
drying at higher temperature should reduce the amount of crystallization; however 
in practice it promoted glass crystallization, possibly due to accelerated ion 
diffusion that led to fast nucleation, which developed over the long sintering time. 
In addition, a high drying temperature risks early breakdown of the polymer 
network, thus the maximum drying temperature was taken to be 125 °C. More 
detailed discussions are in the next section. 
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Figure 5.6 SEM images of scaffolds sintered at 700 °C having been dried at a) 
100 °C, b) 125 °C and c) 150 °C 
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5.3.4 Influence of the sintering temperature 
Figure 5.7 shows XRD traces for the ICIE 16 scaffolds dried at 100 °C, 125 °C 
and 150 °C for each different sintering temperature, while Figure 5.8 shows the 
corresponding SEM images. According to Figure 5.8, drying at 125 °C suppressed 
the K3Na(SO4)2 formation to a minimum, however this contradicted with the XRD 
data (Figure 5.7). The XRD data suggested drying at 100 °C was the optimum 
(Figure 5.7a), the degree of crystallinity increased as the drying temperature 
increased to 125 °C (Figure 5.7b), and was similar to that of 150 °C (Figure 5.7c). 
This means the crystallisation temperature of the glass was reduced and drying at 
higher temperature promoted the onset of glass crystallisation by increasing the 
ion diffusion rate. As the sintering temperature increased above 700 °C, scaffolds 
dried at all temperatures began to crystallise, the amount of crystallization was 
small as the amorphous halos were still present. The crystal phases were a mixture 
of potassium sodium sulfate (K3Na(SO4)2), and sodium calcium silicate 
(Na2CaSi3O8) (01-077-2189). This means that the gel-casting process and the 
presence of water, combined with the slower heating rate had reduced the Tc onset of 
the glass to a lower temperature (<700 °C) compared to the Tc onset that was derived 
from the DSC trace in Figure 3.1 (725 °C).  
 
A low sintering temperature could suppress crystallisation of the glass and growth 
of the K3Na(SO4)2 crystals, but sintering was not efficient at temperatures below 
680 °C and therefore the desired sintering temperature was between 680 °C and 
700 °C for both glass compositions. 
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Figure 5.7 XRD traces of ICIE 16 scaffolds dried at a) 100 °C, b) 125 °C 
and c) 150 °C and sintered at different temperatures  
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Figure 5.8  SEM images of ICIE 16 dried and sintered at different 
temperatures 
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For the ICIE 16M samples, a different result was observed. Whilst drying at 
100 °C (Figure 5.9a) provides the least crystallization, an increase in drying 
temperature from 125 °C (Figure 5.9b) to 150 °C (Figure 5.9c) reduced 
crystallization. However the corresponding SEM analysis disagreed with the 
above statement, in Figure 5.10, the best structure was observed in the middle, 
where drying temperature was at 125 °C and 150 °C while the sintering 
temperature was 700 °C and 710 °C. In general, less crystallization was seen under 
all conditions in ICIE 16M compared to ICIE 16. This indicated that ICIE 16M 
sinters better and has a higher crystallization temperature than ICIE 16.  
 
a) 
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Figure 5.9  XRD traces of ICIE 16M scaffolds dried at a) 100 °C, b) 
125 °C and c) 150 °C and sintered at different temperatures 
b) 
c) 
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Figure 5.10  SEM images of ICIE 16M dried and sintered at different 
temperatures 
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Although in XRD data there was little improvement seen by increase the drying 
temperature, in ICIE 16M there were even more crystallization occurring at 
125 °C than at 100 °C. In the SEM graphs, sodium potassium sulphate 
crystallization were clearly visible in all the scaffolds dried at 100 °C, which was 
improved by increasing the drying temperature 125 °C, until it re-appeared again 
at 150 °C.  A possible reason for this disagreement between data is that at 125°C 
the crystal growth was suppressed but not the nucleation, resulting in smaller 
crystals but greater in numbers. In dissolution the crystalline and amorphous phase 
dissolve at different speeds, larger crystals dissolve slowly and may cause very 
uneven breakdown of the network and unsteady ion release, whereas smaller 
crystals would not have such problems. Hence 125 °C was chosen to be the 
optimum drying temperature (could be increased to 150 °C for ICIE 16M). At 
700 °C there was minimum crystallization of both the glass and the sodium 
potassium sulphate, therefore it was chosen as the optimum sintering temperature, 
for ICIE 16 it was lower (between 680 °C and 690 °C), as ICIE 16 had a lower Tc 
and smaller sintering window than ICIE 16M, as discussed in Chapter 3. 
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5.4 Summary 
Optimum thermal processing program (as shown in Figure 5.11) was deducted to 
promote sintering while suppressing crystallization of sodium potassium sulfate. 
The optimum drying temperature was 125 °C and can be increased to 150 °C for 
ICIE 16M, Drying at higher temperature promoted the onset of glass 
crystallisation by increasing the ion diffusion rate, however crystal growth rate 
seemed to be suppressed, resulting the presence of large amount of small crystals. 
The optimum sintering temperature was 700 °C for ICIE 16M and between 680 – 
690 °C for ICIE 16 as it had a lower Tc and smaller sintering window. Less 
crystallization was observed in ICIE 16M than ICIE 16, which confirmed with the 
results derived in Chapter 3, ICIE 16M is better at sintering than ICIE 16. For 
optimum sintering, the size of the glass powder must be around 10 µm, otherwise 
the structure would collapse and the particles would not sinter together due to 
mismatched packing. However it would slightly shorten the sintering window.  
 
 
Figure 5.11  The optimized thermal process program 
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6 Characterization of the optimized gel-cast scaffold 
6.1 Introduction 
This chapter aims to characterize the optimised scaffold to investigate whether it 
meets the standard of an ideal scaffold for bone regeneration. First the 
compressive strength was examined; then the interconnect size was determined to 
see if it is sufficient for blood vessel penetration and tissue ingrowth, i.e. greater 
than 100 µm by Mercury Intrusion Porosimetry (MIP) and X-ray 
microtomography (µCT); finally, the rate of formation of the apatite layer on the 
scaffold and the ion release rate in SBF were studied by applying FTIR, XRD and 
ICP. 
 
6.2 Experimental 
6.2.1 Compressive Strength 
Bone is a load bearing material hence it is important for the biomaterial to match 
the compressive strength of porous cancellous bone (2-10 MPa [107]). The 
compressive strength of the optimum scaffold was determined using a Zwick/Roell 
Z2.5 tester with a 2 kN load cell and a strain rate of 5 mm/min. Samples were 
cylinders, 6 mm in diameter 11 mm in height and the test was carried out on 10 
samples for ICIE 16 and 5 for ICIE 16M. The results were summarized in Table 
6.1. 
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6.2.2 Pore and Interconnect Sizes 
Micro-CT 
µCT imaging can image objects in 3D and is non-destructive. Novel image 
processing algorithms can be applied to the images for quantitative 
characterizations. It is possible to calculate the key macroscopic structural features 
of pore and interconnect aperture size [123], as well as the porosity plus the 
homogeneity of the foam [124]. The 3D images can also be converted into 
computational fluid dynamic models to calculate the permeability of the scaffold. 
The resolution of µCT scanning is mainly limited by its field of view, which is 
approximately 1/1000 of the sample diameter. The critical resolution required for 
trebecular bone and tissue scaffolds studies is 10 micron, which is one tenth of the 
minimum interconnect diameter required for an ideal scaffold (>100 µm). For 
looking at the pore distribution and homogeneity of the foam, it was possible to 
scan the whole scaffold (maxium 10 mm in diameter with preferable resolution) 
without destroying it; however for the calculations and quantifications, higher 
resolution was required. A 5 mm cubic specimen was µCT scanned using a 
laboratory based system (Phoenix X-ray Systems and Services GmbH) operating 
at 100 kV and 100 μA. Scans and image analysis were carried out by Sheng Yue, 
due to the complexity of the interconnected pore structure involved. The procedure 
for scaffold quantification was improved from previous studies, which quantified 
sol-gel foam scaffolds with approximately spherical pores [123-125]. Details are 
in Appendix A. 
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Mercury Intrusion Porosimetry (MIP) 
It is a physical process of quantitative analysis of pore size distribution within a 
sample. The analysis is based on the fact that mercury is a strongly non-wetting 
liquid on most substrates and it has a high surface tension, which would allow it to 
penetrate through the whole structure with ease under pressure. The Washburn 
equation (Equation 6.1) is applied and the pores are assumed to be spherical [126].  
   
          
     
 
 (6.1) 
where ΔP is the change in pressure, D is the pore diameter, γMer is the surface 
tension of mercury (480 dyne cm
-1
 in air at 20 °C) and the contact angle θ is 140°. 
 
The interconnect size is determined by measuring the pressure difference at the 
threshold of the pore. As the mercury was flushed towards an opening of a pore 
(an interconnect), pressure would build up as the flow path was narrowed, once it 
passed through the threshold, the pressure was released and would remain the 
same until another interconnect came up. The pressure required to intrude mercury 
into the pores is inversely proportional to the size of the interconnects [76]. 
Samples (cylinders with 6 mm in diameter and 10mm in height) were analyzed by 
Quantachrome PoreMaster 33. Compared to µCT, MIP has several disadvantages, 
firstly it is a destructive method and the samples are at constant risk of collapsing 
under pressure; secondly the assumptions used are accompanied with large errors, 
which means it can only used for comparative studies instead of quantitative 
analysis; thirdly it does not taken into account any closed pores, nor does it 
provide any shape information; lastly as it only measures the opening towards the 
pore (interconnect size), the actual pore size remains undetermined [126].  
  
111 
6.2.3 Bioactivity and dissolution studies 
There are only a few materials that can directly bond to living bone without the 
formation of detectable apatite on their surfaces [127]. Despite this limitation, 
examination of apatite formation on the surface of a material in SBF solution is 
useful as an initial screening test for the bioactivity of the material [127-128]. The 
details in how to prepare 1000 ml SBF solution are summarized in Table 6.1. 
 
Table 6.1 SBF ingredients 
Step Ingredients Amount 
1 Deionized Water 750ml 
2 NaCl 7.996g 
3 NaHCO3 0.350g 
4 KCl 0.224g 
5 K2HPO4·3H2O 0.228g 
6 MgCl2·6H2O 0.305g 
7 
Diluted HCl aqueous solution 
(1M) 
30ml 
8 CaCl2·2H2O 0.368g 
9 Na2SO4 0.071g 
10 (CH2OH)3CNH2 6.057g 
11 
Diluted HCl aqueous solution  
(1M) 
Heat SBF to 37 °C adjust pH 
to 7.26 with HCl drops 
12 Deionized water 
Fill the bottle to the 1 litre mark 
and leave to agitate for overnight 
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Steps must be strictly followed in order because SBF is supersaturated with apatite 
and any inappropriate move during the preparation would result in the 
precipitation of apatite in the solution. The reagents are never to be dissolved 
simultaneously but only after the previous one (if any) is completely dissolved. 
 
The volume of SBF needed = sample weight (g) × 50ml ÷ 0.075g 
(6.2) 
The samples were weighed and the amount of SBF required for each sample was 
calculated according to Equation 6.2, which was then measured using disposable 
plastic pipettes. Note the ratio of material versus SBF (3:2) must be kept because it 
was the critical value at which the active ion release rate was at maximum without 
the compensation in HCA layer formation rate [129]. The sample in SBF was each 
held in a small screw-cap polypropylene container (60ml), which was then placed 
inside the New Brunswick Scientific classic series C24 incubator shaker (set to 
37 °C & 120 rpm agitation rate), only to be taken out (samples filtered and dried) 
when the required time period was met. The variation in SBF pH values (pH at the 
end of time point – pH before sample immersion) and % weight loss (weight 
before immersion – weight after drying) was recorded in Figure 6.4.  
 
Fourier Transmission Infra-red Spectroscopy (FTIR) 
FTIR is a simple but powerful tool to identify specimens quickly; it works by 
shining a beam that is composed of many different combinations of frequencies 
onto a specimen and measures how well it absorbs the beam. Each material 
response to a particular frequency sequence in its unique way and can hence be 
identified by matching the result to the database. [130] 
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After bioactivity tests, the dried specimens were mixed with potassium bromide 
(KBr) in a ratio of 1:100 and ground into powder form, which was then pressed 
into thin pellets. The pellets were scanned by a Bruker Vector 22 machine and a 
WinFirst LITE software for FTIR analysis. The reason to use KBr as a background 
material was because it is an inert, infra-red transparent material [130]. 
 
Inductively Coupled Plasma Spectroscopy (ICP)  
ICP (ICP-OES, Thermo Scientific ICP 6000 series) was used to measure the 
ion-release rate in the SBF, mainly the change in ion concentration of silicon, 
calcium and phosphorus ions as a function of time. In ICP the ions are burnt over a 
stream of plasma in an aqueous solution, the ions will lose or gain electrons during 
the burning, corresponding electromagnetic radiation are emitted. The intensity of 
the radiation is measured to determine the ion concentration inside the solution 
accordingly. In the case of ICIE 16 and 16M, extra ions such as K, Na, Zn, Mg, Sr 
and S were also taken into account. Each data point was repeated at least 3 times 
in order to verify the error. 
 
After the completion of bioactivity tests the solution was collected and kept in a 
fridge to keep extra ion activities to a minimum. They needed to be diluted 10 
times (1 ml sample + 9 ml 2M HNO3) and standards (0, 2, 5 and 20 ppm) needed 
to be made before testing. A standard of 0 ppm was the medium 2M HNO3, and to 
make 2, 5 and 20 ppm standards, the standards of the ions that were to be tested 
were mixed with 3.2 ml concentrated HNO3 and water to make up to a solution 
with 25 ml in total volume. The amount of each ion standards increased as the ppm 
value increased (50 µl for 2 ppm, 125 µl for 5 ppm and 500 µl for 20 ppm).  
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6.3 Results and discussion 
6.3.1 Compressive Strength 
The individual values are summarized in Table 6.2. Figure 6.1 (% porosity versus 
maximum stress) is plotted for aiding a clearer view to the table. Equation 6.3 was 
used to calculate the porosity: 
    
     
     
 
(6.3) 
where Φ is the porosity of the scaffold, ρbulk is the bulk density of the scaffold 
(measured by weight ÷ volume) and ρtrue is the theoretical density of the material 
from which the scaffold is made, in this case it is the density of the glass and is 
taken to be 2.74 gcm
-3
 for ICIE 16 and 2.6 gcm
-3
 for ICIE 16M ( the average true 
densities obtained by Keswani et al. [131]). 
 
For ICIE 16, a scaffold with 79% porosity, modal pore size of ~345 µm and modal 
interconnect size of 144 µm, its compressive strength was 1.9 MPa; in the case of 
ICIE 16M, an 80% porosity with pore size of ~436 µm and interconnect size of 
113 µm, the compressive strength is 2.5 MPa. ICIE 16M is therefore stronger in 
compression than ICIE 16, which was unsurprising as it was proven in Chapter 3 
and 5 that ICIE 16M sintered better than ICIE 16. Note that the results are largely 
depended on the shape of the samples, i.e. whether the top and bottom surfaces 
were absolutely parallel, which was very difficult to achieve for porous glasses 
and the reason of the large deviation in the results. Overall the compressive 
strength increased as the porosity decreased. 
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Table 6.2   Compression tests result summary 
ICIE 16 ICIE 16M 
Bulk Density 
[gcm
-3
] 
Porosity 
[%] 
max 
[MPa] 
Bulk Density 
[gcm
-3
] 
Porosity 
[%] 
max 
[MPa] 
0.504 82 1.22 0.738 72 3.22 
0.532 81 1.79 0.753 71 1.86 
0.437 84 1.48 0.831 68 2.60 
0.498 82 2.00 0.522 80 2.52 
0.688 75 2.31 0.842 68 1.74 
0.704 74 2.82    
0.550 80 1.67    
0.712 74 1.75    
0.578 79 1.88    
0.694 75 2.07    
 
 
Figure 6.1  Maximum stresses against % porosity of both glasses 
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6.3.2 Pore and interconnect Sizes
3
 
Figure 6.2a is a 3D image of the structure of a representative optimized scaffold 
and is the visual evidence of the high interconnectivity and porosity of the scaffold. 
Figure 6.2b shows the data obtained by MIP, from which the modal sizes of the 
interconnect were 128 µm, which corresponded to 80% porosity (measured 
geometrically). Three such scaffolds were scanned and the interconnect size 
distributions from CT image analysis is shown in Figure 6.2c. ICIE16 1 is the 
sample imaged in Figure 6.2a, the mean modal interconnect size of the three 
samples was 140 µm with a standard deviation of 30.89. The image analysis of 
µCT images also allowed quantification of pore size (Figure 6.2d), which had a 
mean modal pore size of 379 µm with a standard deviation of 93.43.  
 
 
 
                                                          
3CT data collected and analyzed by Sheng Yue 
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b) 
c) 
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Figure 6.2  a) A 3D µCT image of an ICIE 16 gel-cast foam scaffold; pore 
network quantification of ICIE 16 by b) MIP; c) the interconnect diameter 
and d) the pore size distributions from image analysis of µCT images 
 
In Figure 6.2d and 6.2d it is clear that ICIE 16-2 had larger modal interconnect 
size and pore size than the other two samples, this is because ICIE 16-1 and ICIE 
16-3 are from the same batch whilst ICIE 16-2 is from another, although the same 
production protocol was followed, there is still a variation in-between batches. 
However this difference did not show in MIP results. MIP gave smaller values 
than the µCT results, the reason is probably because the MIP is not as sensitive as 
µCT in determining the changes of pore sizes.  
 
d) 
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For ICIE 16M, the µCT analysis (Figure 6.3b and 6.3c) determined the modal 
interconnect size was 113 µm with a modal pore size of 436 µm. The sample had 
80% porosity measured geometrically. Figure 6.3a is a 3D density distribution 
image of a section of the scaffold and evidently showed the edge of the scaffold 
was denser than the centre, indicating an inhomogeneous sintering was taking 
place. Overall ICIE 16M sintered better than ICIE 16, as the interconnect size and 
the pore size were both much smaller compared to ICIE 16, which is a result of 
enhanced viscous flow during sintering. 
 
 
 
b) 
a) 
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Figure 6.3 a) A 3D density distribution of a section of the ICIE 16M scaffold, 
with density increases as the color changes from blue (cooler color) to red 
(warmer color); pore network quantification of ICIE 16M by µCT imaging 
analysis, b) is the interconnect diameter distribution and c) the pore size 
distribution  
 
 
  
c) 
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6.3.3 Bioactivity and dissolution studies 
FTIR, % weight loss and change in pH 
ICIE 16 scaffold with a bulk density of 0.52 gcm
-3
 and a porosity of 81% and ICIE 
16M scaffold with 0.78 gcm
-3
 density and 73% porosity were immersed in SBF for 
the purpose of deposition and dissolution rate studies. The deposition of HCA was 
inspected by FTIR and the results were summarized in Figure 6.4a and 6.4c 
respectively.  
 
It is clear that for ICIE 16 the deposition of calcium phosphate occurred after 8 h 
of immersion in SBF, as vibrational bands for P-O bending were seen for the first 
time, which is likely to be amorphous calcium phosphate. Similar bands were 
observed at 72 h for ICIE 16M. Amorphous calcium phosphate deposition has 
previously been found to occur on bioactive glasses prior to HCA formation, using 
synchrotron X-ray diffraction studies [132-133]. The twin bands for P-O bending 
at 576 and 611 cm
-1
 observed after 3 days immersion for ICIE 16 indicate the 
calcium phosphate crystallized into HCA, whereas the crystallization was just 
occurring after 2 weeks of immersion for ICIE 16M. The fact that the P-O bending 
peaks corresponded to HCA was confirmed by XRD (Figure 6.4b and 6.4d). 
Apatite formation in SBF of ICIE 16 was therefore at a similar rate to sol-gel foam 
scaffolds that had a similar compressive strength [107], which is more rapid than 
the ICIE 16M and 13-93 scaffolds.  
 
The reason is that ICIE16 has a network connectivity closer to 2 (2.13 according to 
Table 3.4), whereas the network connectivity of 13-93 is a lot higher, at 2.59 and 
3.00 based on different assumptions [58], as the result of the higher silica content 
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of 13-93. The higher network connectivity means that the glass is less susceptible 
to ion exchange and dissolution, which are the first stages of the HCA layer 
formation mechanism. ICIE 16M performed similarly to 13-93, it seems that its 
theoretical NC value of 2.13 (or 2.55 depending on assumption) was not correct. It 
performed less well than the ICIE 16 scaffolds, which suggest that the network 
intermediates (Zn
2+
 and Mg
2+
) were probably acting more as network formers and 
the NC was close to 2.53 in this case.  
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Figure 6.4  a) and c) are respectively the FTIR traces of ICIE 16 and 16M 
scaffolds immersed in SBF for 2 wks while b) and d) are the corresponding 
XRD traces of glass powder (<38 µm) and after 2 wks SBF
 
In Figure 6.5, it is clear that ICIE 16 lost more weight than ICIE 16M after 2 
weeks immersion in SBF. ICIE 16 lost 22% of its mass within the first 8 h of 
immersion (10.5% to 21.5%). For ICIE 16 M, it took 24 h to lose a similar amount 
(from 4.8% to 23.9%). After these time points, the weight loss of ICIE 16M was 
small (23.9% to 27.2%), unlike ICIE 16, which the rate of weight loss was still 
fairly rapid (from 21.5% to 35.1%).  
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Figure 6.5 a) the pH and % weight loss of ICIE 16 throughout the time 
immersed in SBF and b) the same for ICIE 16M 
 
Both scaffolds experienced an increase in pH change (pH after immersion - pH 
before immersion) (0.23 to 0.91 for ICIE 16 and 0.03 to 0.59 for ICIE 16M) with 
ICIE 16 being more active than ICIE 16M yet again. The results confirmed the 
FTIR data that ICIE 16 scaffolds are more bioactive than ICIE 16M scaffolds.
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Dissolution 
Figure 6.6 shows the dissolution (ICP) data. Ca, P, Si, K, Na and S were all 
released slowly into the SBF for both glasses, in addition to the extra ions such 
as Sr, Mg, Zn for ICIE 16M.  
 
Theoretically the longer the soaking time of scaffold in the SBF, the higher the 
silicon ion concentration due to the breaking of the glass network. The 
concentration of calcium ions will also increase throughout time, but it will 
decrease again after a certain amount of time, which is when calcium starts to 
deposit along the glass surface. On the contrary, the phosphorus ion 
concentration will decrease over time, due to the formation of HCA layer on the 
glass surface. In practice, the phosphorus was taken up by the sample from the 
solution and none was left after 1 week of immersion for ICIE 16, indicating P 
deposition on the glass; which is not the case for ICIE 16M, after 2 weeks there 
was still 15 ppm of P in the solution which confirms slower apatite formation in 
ICIE 16M than in ICIE 16. After 1 day of immersion of the ICIE 16 scaffold in 
SBF, there was an increase of phosphorus in the solution but a decrease in all 
other elements except calcium. It is therefore possible that some amorphous 
calcium phosphate deposited on the glass and then redissolved before 
reprecipitating on the glass again. This has been observed in sol-gel derived 
bioactive glasses using synchrotron XRD [134-135].  
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Interestingly, there is a correspondent drop in pH change in Figure 6.2a at the 
exact time point, which could be a result of this phenomenon. Approximately 35 
ppm for ICIE 16 and 37 ppm for ICIE 16M of sulfur was released into the 
solution after 2 weeks, which was from the potassium sodium sulfate crystallites. 
From Figure 6.6b it is not clear whether all the sulfur crystals were degraded or 
not, but the majority was released during the first 8 hours of immersion. Sulfur 
in its element form is non-toxic and a vital component of all living cells, at a 
quantity this small it is unlikely to provoke any response from the body.  
 
Sr and Mg were released readily into the solution for ICIE 16M but Zn behaved 
rather strangely. Considering the mol% of the three elements were exactly the 
same (3 mol%) in the composition, not only was the released amount extremely 
low (maximum at 0.23 ppm) compared to the Sr and Mg (23 ppm and 53 ppm 
respectively), but after 8 h there was a sharp decrease (from 0.23 to 0.13 ppm) 
and after 1 day it reached a saturation at 0.07 ppm. This means that Zn was not 
released from the network, and after a small release of Zn ions into the solution, 
it was taken up again possibly by the glass or the orthophosphates and formed a 
stronger bond with either of them, which prohibited the further release of Zn 
ions. This evidently confirmed that Zn ions, unlike Mg ions which were also 
network intermediates, were acting as network formers in this case, and this 
could be the reason that ICIE 16M was very slow in forming crystalline HCA. 
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a) 
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b) 
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Figure 6.6 ICP traces of a) P and Si ions, b) K, Ca and S ions for ICIE 16 
and ICIE 16M glass, in addition to c) Sr, Mg and Zn ions for ICIE 16M 
c) 
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In section 3.2 the NCs were calculated and summarized in Table 3.2, which can 
now be revised according to this discovery of the role of Zn in ICIE 16M, the 
revised version is Table 6.3: 
Table 6.3  The NC values of different glasses revised  
Glass NC value 
Bioglass
®
 45S5 2.11 
ICIE 16 2.13 
ICIE 16M  
(Mg
2+
 as modifier and Zn
2+
 as former) 
2.35 
 
6.4 Summary 
The pore and interconnect sizes are different for different batch of samples 
produced under the same protocol and conditions. ICIE 16M scaffolds have 
greater compression strength than ICIE 16 scaffolds due to superior sinterbility. 
Both scaffolds have met the interconnect size requirement (128 µm for ICIE 16 
and the 113 µm for ICIE 16M) for an ideal scaffold (> 100 µm). The pore and 
the interconnect sizes for ICIE 16M were both smaller than ICIE 16, as an 
evidence of better sinterbility of ICIE 16M. After immersion in SBF for 2 weeks, 
ICIE 16 (amorphous HCA formation at 8 h which crystallized at 72 h) 
outperformed ICIE 16M (amorphous HCA formation at 72 h and just started to 
crystallized at 2 weeks) in apatite formation rate in SBF, which is because the 
network intermediates are acting as network formers and resulting in a larger 
network connectivity value for ICIE 16M. 
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7 Conclusions and future work 
7.1 Conclusions 
Highly interconnected 3D porous melt-derived BG scaffolds were successfully 
fabricated using the gel-cast foaming technique; the standard protocol to 
produce optimum foam structure was derived, which consisted of 20 g glass 
powder, 18 ml water, 6 g acrylamide (monomer), 3 g N’ N’-methylene 
bisacrylamide (cross-linker), 2 ml ammonium persulfate (APS) solution 
(initiator), 0.1 ml Triton X (surfactant) and 4 ml tetramethylethylene diamine 
(TEMED) (catalyst). The more water, the less catalyst and the less initiator, the 
longer the gelling time with a greater foam body volume; on the contrary, the 
more the initiator in the solution, the larger the foam body.  
 
A suitable drying program was verified to be at 125 °C for 10 hours. A two 
stage sintering program for optimum sintering was also determined, where at 
first it was ramped at 2 °C /min to 350 °C, held for 1 hour and ramped up again 
at 2 °C /min to 700 °C, held for another hour, in order to burn out the organic 
components and sinter the glass particles.  
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The modal interconnect size was 128 µm for ICIE 16 scaffolds and 114 µm for 
ICIE 16M ones whereas the modal pore size was 379 µm and 476 µm 
respectively. After 8 hours immersion in SBF, amorphous HCA was formed and 
crystallized in 3 days for ICIE 16, and the ICIE 16M formed amorphous HCA in 
3 days, which just started to crystallize after 2 weeks of immersion. The 
compressive strength was determined to be around 2 MPa for ICIE 16 and 
slightly stronger for ICIE 16M scaffolds at 2.6 MPa. 
 
Overall, ICIE 16M was better for processing than ICIE 16 whilst ICIE 16 
outperformed ICIE 16M in bioactivity studies. The ICIE 16 scaffolds would be 
more suitable as new artificial bone graft materials. 
 
The gel-cast foaming process can be applied to fabricate highly porous and 
interconnected scaffolds made of any melt-derived BGs, with only small 
modifications required at specific parameters e.g. the sintering temperature, and 
there is immense potential for mass production. 
  
 
 
 
 
 
  
134 
7.2 Future Work 
The role of Zn in ICIE 16M requires further investigation, the best way to do so 
is carry out 
29
Si Nuclear Magnetic Resonance (NMR) spectroscopy on both 
ICIE 16 and ICIE 16M to see whether the addition of Zn has had an impact on 
glass structure. If Zn is indeed acting as a network former, there will be more 
NBOs in ICIE 16M than in ICIE 16, which can be identified as the peak will 
shift towards the negative side of the spectrum. 
 
The crystallization of potassium sodium sulfate was unavoidable when using the 
methacrylamide gelling system. Melt-derived BGs other than ICIE 16 and 16M 
might not suffer from the same phenomenon depending on the composition, 
however it is likely that if a glass is reactive enough to be bioactive it is likely to 
suffer this problem if water is present. Although it may not be a great issue in 
terms of biocompatibility and can be controlled by reducing initiator content as 
well as modifying the drying/sintering program, it is sensible to explore other 
options. Many gelation systems have been developed, mainly based on water 
soluble epoxy resin and sodium alginate as gel formers. For epoxy resin gelling 
system, the gelling time was extremely long (>45 minutes in general) and the 
sintering temperature required for burning out the organic parts were too high 
(>1000 °C) [136-139]. For the sodium alginate gelling systems it is possible to 
control the gelling time by applying different reagents [140] but the setting time 
takes a few hours, despite complicate process and the prolonged preparation 
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time of the sodium alginate solution [141]. Therefore such systems are not 
suitable for the purpose of this study.  
 
Potozeck et al. produced highly porous HA foams by using agarose as the 
gelling agent, Tergitol TMN-10 as the surfactant and agitate the slurry at 65 °C 
[142-143], gelation occurred when the foam was cooled to 15 °C. The pore 
network was controlled by the vol% of HA in the system and agarose 
concentration, mean pore size ranged from 130–380 µm and 37–104 µm for 
interconnect size. Porosity ranged from 73–92% as mechanical strength 
decreased from 5.9–0.8 MPa. Agarose is a substrate of red algae and have been 
long used as a food ingredient, therefore it is completely safe and hazard free. 
Gelatin based gel-cast system works in a similar way to agarose [144] where the 
slurry was agitated and foamed at 30 °C, then cooled to around 10 °C for 
gelation to take place and Fongraminox KC-B was used as the surfactant, the 
gelling time was about 23 min, the scaffold properties remained uninvestigated 
[145]. These two systems are the potential candidates for a safer, sulfate-free 
gel-cast foaming system that require a thorough investigation to determine the 
standard processing protocol.  
 
Cell culture studies also need to be carried out to investigate the cell attachment, 
cytotoxicity and LIVE/DEAD viability of the scaffold. 
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Appendix A – 4-step µCT image analysis process4 
1. A 3×3×3 median filter was applied to remove the noise and then the image was 
binarised into two phases: the struts and the background (void spaces which 
were identified as the pores). A 5×5×5 morphological closing operator (dilation 
followed by erosion) was then applied to remove the fine intra-strut porosity, 
which otherwise reduces the watershed accuracy (step 3 below).  
2. A distance map was then generated by successive dilation of the strut phase 
until all the pore voxels were filled. The distance function is then the number of 
steps need to reach that voxel in the pore, while the final voxels to be filled, or 
regional maxima in the distance in the 3D distance map, were tagged as the 
macropore centroids [123-124].  
3. A 3D watershed algorithm [146] was then applied to the distance map and 
centroids. A watershed algorithm uses the rise and fall the distance map values 
to group voxels together where any water falling on those voxels would all run 
down to the same local minima. Here, the distance map is inverted and the 
lowest values at the struts are high point ridges where the water sheds into the 
centroid segmenting the space between struts into different macropores. Once 
the marcropores are defined, the interconnects are easily identified as groups of 
voxels touching two macropores.  
 
                                                          
4
This information is provided by Mr. Sheng Yue, who has also carried out all the µCT analysis. 
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4. After the pore space was segmented thoroughly, the sizes of each pore and 
interconnect could be represented by their equivalent diameters. The equivalent 
diameter of a pore was the diameter of a sphere that has the same volume to this 
pore. The equivalent diameter of an interconnect was firstly quantified by using 
a principal component analysis (PCA) based method [125]. This particular 
method found the best fit principal plane to each interconnect and projected all 
the voxels that belonged to that interconnect to the principal plane. The diameter 
of a circle with the same area of the projected voxels shade was the equivalent 
diameter of the interconnect.  
 
